#paid clinical trials in texas | Explore Tumblr posts and blogs

rickstexaschick · 6 years ago

Text

Rick’s Texas Chick: Chapter 8

Originally posted on AO3: https://archiveofourown.org/works/15183545/chapters/35229917

In a slow, even voice she told Rick the story. How they’d met at the hospital where she worked, she a staff nurse, and he a trauma surgeon. He’d recently immigrated from South America, hired to join the medical school faculty. They’d met at a happy hour at a nearby pub that catered to the hospital staff, otherwise they probably would have never run into each other at the hospital.

She didn’t ‘do’ trauma, she said, quietly, wrinkling her face in distaste, keeping her eyes closed while she continued talking.

Couldn’t handle the blood, the horrific injuries, the patients’ screams of fear and pain, their family members standing outside the shock room, crying, demanding to know what was happening. All the chaos and rush, everyone shouting out orders, trying to attend to everything at once. It always sent up feelings of panic inside her, and she struggled not to give into the urge to burst into tears and run away. Like she was the one who’d been hurt. Her advisor in school had told her that that was just a part of her natural empathetic nature, that she’d get over it. But she never could.

She much preferred dealing with patients once they were sewn up, drugged up, no bones sticking out or intestines spilling out of knife wounds slashed across the gut, and no longer spurting blood or other body fluids out all over the place.

In spite of this, they’d hit it off and were soon dating. He was so confident, so sure of himself in an emergency and in his skills as a surgeon. When they first met, she used to go down and watch him in the ER, to watch him in action when a trauma patient came in. Directing orders right and left, he commanded the room with effortless ease. He was unmistakable even when he wore a surgical mask: his tall body towered over everyone else, his shock of blue-gray hair visible even as he bent over to administer to a patient. There didn’t seem to be anything he was afraid of.

By comparison, sometimes he made her job feel dumb and silly. Her told her that her job just amounted to wiping asses and pushing pills, and she had to agree. He was everything she wasn’t, and yet he still wanted her. He was a god, her god, and they were married less than year after they met.

She was quiet for a moment.

She wasn’t young when they’d met, neither of them were---he was 10 years older than she was and divorced. He never really talked about his past life that much. Unlike her. He said he’d left his ex-wife behind in South America so he could start over in the US, where she couldn’t get her hands on anymore of his money. That was as much as he was willing to tell her. And she believed him.

Her friends urged her to move more slowly. They didn’t like how he treated her: condescending, arrogant. Always impatient, always criticizing her, ridiculing her.

She’d defended him. They were misinterpreting it, that’s all. It was just a cultural thing.

And besides, she acknowledged privately, the way things had been going for her, she’d thought she’d never get married. She’d be a fool to let this opportunity slip away.

“My mom and dad were soooo happy that I’d found a doctor to marry,” she went on again, quietly. “Like that was the be all and end all to life…”

More silence. Rick slowly rubbed her muscles without speaking.

“And boooy, did they love him. He had them wrapped around his finger. They thought he hung the fucking moon...

“But after we got married, I couldn’t tell them what he was really like. I was too ashamed.”

After they married, he discouraged her from maintaining her friendships. They were all losers, they’d only hold her back, drag her down. Besides, they didn’t even want her to marry him. How could she, he asked, stay friends with them after all the bad things they’d said about him? What kind of person was she that she could do that? They certainly weren’t welcome at his house---their house, she corrected him.

He’d reached out like lightening and grabbed her hair. “Who paid for this house, slut? Who pays the bills around here? Me, I do. This is MY fucking house, and they are NOT coming here. EVER.”

So, she tried meeting them outside of the house: an early dinner, happy hour, always when he was working or out of town, so he wouldn’t know. But whenever he found out about it he would give her the silent treatment for a week. It was painful, it was pointless to keep trying.

So, she’d let them all go, one by one.

“And your parents?” Rick asked.

I can’t talk about that, was her cryptic response.

She paused for a moment, then went on, talking about her ex. Describing how ambitious he was, had huge plans for a successful academic career here in the US. He was always working towards that end. He traveled frequently to conferences, accepted invitations to give guest lectures – always for money, of course, with all his expenses paid. He never did anything for free. He wrote journal articles, collaborated on textbook chapters with other trauma surgeons from schools around the country, participated in lucrative clinical and pharmaceutical trials...He was always busy, always building his empire.

Because of work, she couldn’t travel with him as much as she would have liked, but he never seemed to mind. In fact, very quickly he’d begun discouraging her from joining him. He’d suggested that she stay behind, focus on herself, her career.

It was he who’d brought up the topic of her going back to school. Before that, she’d never really given it much thought. She’d always been content to continue working as a nurse.

It was an embarrassment to him, he’d said, that she was ‘just a nurse.’ He’d told her this on more than one occasion. He didn’t like introducing her to his colleagues and professional visitors. He’d made her feel ashamed of herself, as if she wasn’t worthy of being by his side.

The other doctors’ wives were either doctors themselves, or trophy housewives: involved in Junior League, charities. More than that, they were always dressed immaculately, hair and nails done, always skinny, never out of shape. Or, god forbid, fat.

She stopped, and in the quiet den this last word hung in the air over them like a balloon, the unspoken humiliation and shame clung to it like two lead anchors, never allowing it to dissipate and break free from her psyche.

Rick could almost see how they permanently draped around her neck, scarring her, holding her down from ever achieving any semblance of self-respect and happiness. It broke his heart, hearing her talk about herself this way.

She went on....

She’d known this wasn’t entirely true, she said, but her ex refused to hear her side. In their marriage, he was always going to be right, and she was always going to be wrong. Someone had once told her that in marriage, if one had a disagreement with one’s spouse, you had to decide: Would you rather be right or would you rather be happy?

Well, she’d never been either one. But she had to make the best of it.

So, she tried. She curbed down the tomboy in herself, stopped working in her garden —hired landscapers. She wore the expensive clothes, tried to dress and act more femininely for him. She got her nails and hair done regularly, wore more make-up. But she hated it. It didn’t feel like who she really was inside. And it still wasn’t good enough for him.

It was only then that the truth had begun to dawn on her.

It had nothing to do with if she was a nurse or not. Not entirely. She would never be good enough. She would never, could ever be any kind of ‘trophy wife’ to him, no matter how hard she tried.

Ultimately, it just wasn’t in her nature to be that kind of woman, lead that kind of life.

So, she’d stopped trying to be a trophy, and went back to being just herself.

Just herself, the words echoed in Rick’s head, as he quietly rubbed her shoulders. As if that was of lesser value than the farce of living your life, struggling to pretend to be something you weren’t, for someone who clearly didn’t give a shit about you except to bend you to his will.

She continued……..After that, her ex resumed his attack on her chosen profession. He was ashamed to be married to her, she was beneath him as a nurse. He pressured her to change her profession entirely. Wanted her to go to med school.

But at that, she had put her foot down, literally. It only goaded him to try harder. He pushed and pushed, day after day, wouldn’t let the subject drop. But uncharacteristically, stubbornly she’d refused to go along with his recommendation, his demands, wouldn’t even entertain the idea.

Finally, during one argument she’d totally lost it. She stamped her feet to punctuate each word and shouted at him in frustration and anger at his arrogant refusal to listen to her and what her real needs and goals were. She.Did.Not.Want.To.Be.A.Doctor. She’d lost he composure. Screaming, throwing a tantrum almost like a 2 year who didn’t want to take an afternoon nap. His blue eyes became ice cold. Losing control of herself like that in front of him was never allowed. It was something he hated and thought of as a weakness. It was the biggest fight they’d ever had.

He’d abruptly left her for three days, with no word of where he’d gone or if he planned to come back. Didn’t return her calls, texts, or emails. It was like he’d dropped off the face of the earth.

She’d gone almost insane with worry. Even strayed down to the ER looking for him, where she’d finally learned that he was out of town at a trauma conference. It was the ER nurse manager who’d told her this on the third day, a look of pity in her eyes as she told her.

Belatedly, she realized what it must have looked like for the wife of one of the trauma surgeons to come looking for her husband, clearly not having a clue that he’d left town.

Left town and taken an ER nurse with him, as it turned out, and not for the first time—but this latter detail she wouldn’t find out until sometime later.

After three days’ absence, he came back home all kisses and light, as if nothing had been amiss. When she tentatively brought up the topic of school again, he refused to discuss it. Told her she was a big baby and if she was too afraid to grow professionally, and couldn’t appreciate how he was willing to help her, then he didn’t want to waste his time with her.

She persisted, telling her plans to him. How she’d compromise, and agreed to return to school to become an NP. He’d laughed in her face, unimpressed. He told her she was taking the easy way, settling. Again. Just like how she’d ‘settled’ to become a nurse in the first place.

Once again: not good enough.

Undaunted, she’d found a program at a local university which offered dual masters degrees—simultaneously earning two degrees with minimal extra course work, and only one thesis. She thought this would placate---even impress him, but then she made the mistake of mentioning to him that it would mean she’d have more degrees – and, technically, more education – than he. Her two bachelors and two masters to his one bachelor and medical degree. She'd meant it sort of as a joke----of course she knew she'd never be more than he was. He was a doctor, a renowned trauma surgeon.

But it backfired. He was always sensitive about his foreign education. Even more so, his ego refused to accept that she’d ever be any more, any better than he was, and certainly never an equal. The mockery in his eyes instantly shifted to one of blind outrage.

In his rage and anger, he reached out with one swipe of his long arm and struck her backhanded across the face, violently knocking her to the floor in their bedroom. His surprise outburst shocked her and she huddled there momentarily, almost knocked senseless. Gathering her wits while stars swirled in her vision, she tasted blood in her mouth where her teeth had cut the inside of her cheek, and blood trickled from her nose and from her split upper lip, oozing down in two rivulets that dripped off her chin.

Wiping her face, she started to stand back up. Snarling wordlessly, he’d grabbed her by her hair and shoved her face into the carpet, placing one long, bended knee down into the small of her back to hold her down. She knew he would have killed her right then and there. But adrenaline surged through her and she found the strength to wrench away from him. She pushed herself back up to her feet and jumped out of his reach. She stared up at him defiantly with hatred and anger in her eyes, refusing to be cowed even though he towered over her, seething with rage.

Without another word, he’d turned on his heel and left the room. The house. They didn’t see each other again for weeks.

It was not the first time he’d struck her. But it was the first time he’d left such blatant marks for others to see. She had to call in sick to work for the rest of her week’s shifts, to allow the cuts to close and the bruises to fade to the point where she could cover them up with heavy make-up, until they were gone completely.

So, after all the months of tears and fighting, after she’d finally agreed to go back to school, it was with only half a heart on her part, and no support or encouragement from him.

Because it wasn’t med school he’d refused to help pay for it, even though they had more than enough money. He told her he didn’t support charity, and besides, it would make earning the degrees all the more rewarding for her, he said, knowing that she’d done it all on her own.

It was a load of crap, of course, but what could she do. So, she’d had to keep working full time and could only attend classes part time. She’d taken out a huge amount of school loans, too. Going part-time made it take twice as long for her to complete the degrees, which had cost her even more money, in the long run…

While she was preoccupied with grad school, he’d quickly risen through the faculty ranks and was eventually named the new Trauma Director. His ego and arrogance kept growing.

He kept to himself while she slaved away at her books. Somehow their schedules worked out so that they were never off on the same days. On her days off, she stayed home at their house in the suburbs, studying, writing papers. The program slogged on, took longer than she expected. Her thesis research had taken up an entire semester in and of itself. She hated research — that’s probably why it had taken her so long to complete it. She just kept putting it off. Then she had to write the thesis and submit it to her advisor. An endless series of revisions and re-submissions took up another semester. She wondered if her advisor had grown as sick of her paper as she had.

Increasingly, her husband spent many late nights and weekends at the hospital. She’d thought he was finally showing her some consideration and kindness by leaving her to her studies, to keep from distracting her.

For surely, as the Trauma Director, he didn’t have to work those kinds of shift any longer…?

Eventually, she found out that he'd bought a high-rise penthouse near the hospital. Had had it for years, she never knew about it. It had never occurred to her that he would do something like that without telling her. He’d said it was for those days when he was post-call, so he wouldn’t have to risk having an accident driving home after being awake for so long. He made it sound like it was nothing, just a convenience for him, one that should have made perfect sense to her, so why, his tone seemed to ask, was she questioning it?

She’d believed him, of course. Like she’d believed all his lies.

She subsequently found out he’d also gotten it for late-night entertaining of nurses from the ER and dancers at local strip clubs.

By then she’d finished school and was focusing on her new job and career.

By then his penchant for after-hours entertaining the nurses from the ER was a well-established and not-so-well-kept secret. Everyone knew about it, except for her.

By then their relationship had drifted apart so much, she thought she just didn’t care anymore.

She grew quiet, her thoughts taking her down a lonely path of dark memories.

“What’s his name?” Rick asked softly, although he already suspected what it was.

A long moment of silence passed before she whispered, “Ri-Ricardo. Rick.”

He nodded grimly.

“And, let me guess: we both look alike.”

“No. Well, kind of. You’re both tall. But he’s been getting fat, all those free pharmaceutical lunches and dinners. He’s stopped working out. And he wears his hair in a sort of tall flat-top. It's so thick, it makes it stand up kind of like a fur brush. His skin is darker-complected, being Latin American. I think he has a lot of Native South American or Indian in him or something. His mother was from Spain, but I think his father’s family has been there for generations. He never really talked about his family or anything like that. He always said it wasn’t important. He always said that since I was never going to meet them, what did I care?

She went on. “They hyphenate their family names down there, you know, keeping both parents’ names. But he dropped his father’s name when he came to the US, and just went by his mother’s: Garcia. But it’s really Sanchez-Garcia. Funny, huh? That you have similar names? I know they’re both common names, like ‘Smith’ or ‘Johnson.’ It’s just a coincidence that I’ve met two men with close to the same name, and y’all look like you could be cousins, or distant relations with some of the same DNA popping up out of the blue. Maybe he's your doppelganger...”

She still wasn’t putting two and two together, even though to him it was so obvious.

But then, why should she? How could she know that there were infinite dimensions, infinite Ricks? And one had decided to drop in on his dimension and make himself right at home.

Beneath him, she swallowed, licking her lips.

“I need to drink something.”

So do I, he thought.

Silently, Rick handed her glass to her, the ice had completely melted. He sat back on his heels while she propped herself up on her elbows and finished it off, leaving the olives and lemon peel as discarded refuse at the bottom, then he placed it back on the table before waiting for her to lay back down again.

She wriggled her shoulders to settle in. “Thanks for listening,” she said quietly, after a moment or two.

He smiled down at the back of her head wryly. “You really didn’t give me much choice, did ya, babe?” He threaded one large, warm hand through her soft wavy hair and gently ruffled it.

She giggled, “No, I guess not. But it feels good to talk about it. Get it off my chest.”

He had been listening with growing interest, despite his initial misgivings. And now he was glad he’d heard her story out. His hands resumed kneading slowly across her shoulders as he considered his next words.

“But you haven’t told me everything, have you?” Rick said, quietly.

She sucked in her breath and grew tense beneath him again. He saw her eyes pop open for the first time since she’d begun this tale, then she squeezed them shut in pain.

“No,” she whispered, shame and humiliation in her voice. Please don’t make me, her voice said to him. He could practically feel her shrinking into herself, underneath him.

He took pity on her. “It’s your story to share, babe. I’m just your masseur for the evening.”

She lay underneath him quietly for a few moments. He thought she’d fallen asleep.

“No. I think I’ll save that for another night of too much gin.”

He chuckled, and suddenly the atmosphere in the room felt more lighthearted, as if a dark spell had broken. He sat back and shifted his position so that he was sitting down on the couch once again. He winced while he slowly straightened out his legs, feeling his knees and ankles pop from being bent for so long.

She rolled over and pulled a lightweight cotton blanket off the back of the couch and draped it across herself. He lifted up her legs and laid them across his lap, his hands absentmindedly rubbing her feet.

His erection had left him long ago.

“So,” he looked down at her with a wink and a grin. “Ya wanna fuck?”

She laughed and lifted up her foot, pretending like she was going to heel him in the groin. “Don’t be an ass!” But her eyes sparkled and her smile was the most lighthearted since the first time he’d met her, he realized.

“But seriously, baby,” he said, leaning down close and holding her face in his hands. “I am not that Rick. I will never, ever make you do anything that you don’t want to do. OK?”

She sucked in her breath. “I know,” she whispered, looking into his eyes.

He bent down and took his lips in hers and gave her a sweet, soft kiss.

tbc

#Rick and Morty Rick Sanchez Rick's Texas Chick Rickdicted Harley Rick

4 notes · View notes

phawareglobal · 3 years ago

Text

Sandeep Sahay, MD and Jordin Rice, RN - phaware® interview 364

Pulmonologist Sandeep Sahay, MD and Jordin Rice, RN from Houston Methodist Lung Center discuss a nurse's role in informing and educating pulmonary arterial hypertension patients about clinical trials.

Sandeep Sahay, MD: I am Sandeep Sahay and I'm a pulmonologist at Houston Methodist Lung Center, Houston Methodist Hospital, Houston, Texas, and I specialize in pulmonary hypertension and I'm actively involved with clinical care of pulmonary hypertension patients and also in clinical research.

Jordin Rice, RN: I am Jordin Rice. I am a research nurse at Houston Methodist. I work directly with Dr. Sahay. We work with all types of PH patients near and far, and I have had the pleasure of becoming a research nurse after caring for them at the bedside. It's just been a wonderful experience. They're some of my favorite patients I've ever met. And I really look forward to talking about clinical trials and how we take care of them and manage their care.

Sandeep Sahay, MD: Let me start with this. What is a nurse's role in informing or educating PH patients about the clinical trials?

Jordin Rice, RN: I think first and foremost, we approach everything as a team. You and I work really closely together, looking at patients, figuring out if people qualify. You obviously know things that I don't. I might think of things about patients that you don't, like their commute, how much time it's going to take away from their normal job to participate in a trial. So nurses I feel like are really instrumental in that process in making this a realistic thing, to be enrolled in a trial. We help logistically get patients here and we talk about kind of the ins and outs of trials. Not all patients are going to qualify for something. It's up to us to really dive into a patient's medical records and talk to them directly about what it means to actually be in a trial. You have to come into clinic a lot. You have to talk to us a lot and get really close to us. So it's important that we establish a good relationship with patients, right from the beginning, to avoid any hiccups and make sure they get the best possible experience out of participating in a trial.

Sandeep Sahay, MD: From the nurse's perspective or especially the research nurse perspective, because in the PH disease state, research plays a very important role and it's important to stay relevant to the newer therapies and also participate in the newer trials so that we can have more treatment options for our patients. So how do the research nurses think about the clinical trials about why it is so important for the patients to enroll? Especially if you are talking to a patient, let's say you are investigator or the PI or the physician asked you, "Hey, contact this patient, maybe for this particular trial." And now you are speaking to the patient and you feel like the patient is probably not ready. So how do you approach those kind of things in your mind? How do you think how important these trials are?

Jordin Rice, RN: I think you first have to understand a patient's knowledge about clinical trials. Some people, they might work with companies in industry. They might have a family member that has participated before, or they might not know anything. They don't even know what placebo controlled means. So getting to know where a patient's starting point is, is typically how I start approaching patients. We recruit tons of different ones. It depends on what type of PH you have. We have to talk to patients why this would even be beneficial to them. A lot of patients think they might be a guinea pig and this doesn't benefit them at all. It just benefits us because we get to learn from them. But that's really not the case. Clinical trials makes medicine more accessible for patients. You can get routine testing, you can get an echocardiogram, a right heart catheterization. You can get doctors' visits, all paid for by the study. Some of our patients are uninsured, undocumented. Some of them are very wealthy. So we see a good variety of people that come in needing the same thing. Whether it's just medical care that can benefit patients, but the substances that we're actually treating them with and testing, they can be really exciting and show the first glimmer of hope of this disease actually being reversible or curable, which is exactly why I do this job. I don't have any interest in keeping up with the status quo. I want to keep advancing science. And I know, Dr. Sahay, you're the exact same way. You're an absolute pusher. So when we see a patient that is potentially eligible, meeting them where they are, making them realize that this disease is chronic, they're going to be dealing with it for their whole lives. Hopefully not. Hopefully, we find some kind of cure or treatment that's going to make it easier, but seeing what their quality of life is and what they want that to look like a few years down the road. We collaborate a lot together on talking to patients and making sure they know what they're signing up for and making sure they know they're not just an experiment. They're a person. These drugs that we're testing are exciting to us, but I hope they're equally as exciting to the patients we talk to. Whether they have the time to participate or not, I just want to open people's minds about research when I have those conversations.

Sandeep Sahay, MD: In your experience, when you talk to these patients, especially about the clinical trial enrollment, have you encountered that there are some obvious barriers? In your experience, what did you find that is the most common cause for them to decline? Or if you have something like that in your mind, then how do you think we could do better in that to encourage them to participate in the trials.

Jordin Rice, RN: Every single one of our patient is human. They typically have a job and some of them have kids. Some of them are living far away. So we have to be realistic in how a trial can fit into their life. Sometimes trials can be every few weeks, sometimes it's once a month. It really just depends on what trial we're talking to them about out. We're also strategic in the trials that we offer to them. I'm not going to offer a trial that you have to be here every single week for somebody that has four kids and a full-time job and is a single mom. That's not going to work for them. However, there are exceptions that we can make and work arounds we can do in order to make these trials work for patients, as well. So if a patient, they live five hours away, we can put them in a hotel room the night before or we can do an early visit, we can do a late visit. We stay well after the 9:00 to 5:00 or well before the 9:00 to 5:00.

Being able to tackle those barriers with patients is instrumentally important. We can't just tell patients Monday at 8:00 AM, you have to be here and no exceptions. We really have to work with them. Also our patients sometimes are not ready for trials. I don't want to say that's a huge barrier, but if they're still getting used to being diagnosed with this disease, if they're freshly diagnosed, getting into an experimental trial might not necessarily be the first option for them. We need to get them on stable therapy. We need to get them comfortable living with their disease before we throw them into something that's unfamiliar, mostly because we have to get patients to manage their own medications and be compliant. That can be easier said than done. We have medications that patients have to take three times a day and be consistent with their diuretics and be consistent with so many things. That's a lot harder when you're living a real life and are discharged from a hospital. So there are several barriers. And sometimes as a nurse, I feel like I can see those or patients are more forthcoming in talking about those to me. Not that they would never talk about it to you, but if you talk about a trial to them, I've seen them say, "Yeah, yeah, sure. I'll participate." Then you leave and close the door. And they said, "What did he say? I didn't really understand that. Can you explain that more?" I feel like I can benefit patients in that way. I just have a different perspective and you are rushing around a lot and you don't have a ton of time. So I feel like I can fill those gaps a lot. And it makes us a really great team.

Sandeep Sahay, MD: How do you think that nurses view enrollment in clinical trials differently than physicians?

Jordin Rice, RN: That is a tough question, and it definitely doesn't have a right answer. It's going to be different for every coordinator, but what really stands out to me with trials, if I'm talking to a patient, is somebody that's just as excited as I am and just as willing as I am, because I'm willing to jump over barriers and go through hoops to get somebody on the schedule and get things that work for them. I want a patient to do that same thing for me, because we're a team once they enter a trial. Sometimes when patients are scared or they're really hesitant to enter, I find it harder to enroll them and get them excited and get myself excited for it, simply because I just want to make sure it's the right step in their care and treatment. If they're hesitant, it honestly makes me doubt that sometimes. There are definitely more issues that come up and more things that we look for in patients, but really that excitement and wanting to participate in research is something that I think is so important. I would love for my patients to think that same exact thing.

Sandeep Sahay, MD: What do you enjoy most about working with or treating PAH patients?

Jordin Rice, RN: PAH patients are really special, and if you work with them or if you are one, you probably know the resiliency that you have to have to one, be diagnosed with a chronic progressive disease and two, to live with it. Whether you're on oral therapies or you're doing something like subcutaneous Remodulin, you have to just be very aware of your care and very in tune with how you feel and be an advocate for yourself. Sometimes these patients are just dealt the worst cards. We've had several patients that tested positive for COVID at the beginning of the pandemic and it worsened their disease severely. It's tough to see these things happen, but sometimes they are unavoidable, but seeing patients want to get better and fight every single day to do that is really exciting. I worked with these patients when they got admitted to the hospital. They were getting heart catheterizations. Some of them were decompensating and needing treatment in ICU. I've never seen so much fight in a group of people. Especially since a lot of our patients are rather young and mostly women, it seems like a group that I can relate to, but also every other patient that we have, male or female, young or old, they all seem so just strong. That's the best word I could use. And you probably understand that resiliency yourself. I just really do love treating them so much and working with them. I wish one day I don't have a job because we cure this disease. It's easier said than done, but I hopefully, hopefully think we're going to do it one day.

Sandeep Sahay, MD: I absolutely wish so. Talking to you, one thing which comes to my mind, which my mentor taught me, Dr. Frost... I guess everyone knows her in the PH world... always remember that your clinical trial should be the right fit for your patient and your patient is the right fit for the clinical trial. Every time whenever I think of a patient in a clinical trial, I just sit back for a minute and just think, "Is this trial going to benefit my patient? And is the trial going to get benefit by enrolling this patient?" These are two different things. And I'll be very honest. It took me a little time to really understand this difference. It sounds similar, but it is not actually.

Jordin Rice, RN: I think whether or not you're participating in a clinical trial, you really have to take charge of your care. We see patients that do this and don't do this. The people that do it and take charge of their care and learn and absorb all of the information we give them, they do tremendously better. That goes with clinical trials, as well. You can be passive in your treatment and you can just follow through with the motions. But if you sit down and listen to everything we say and use us as resources and ask questions and navigate support groups online and use resources online, I really do feel like you'll do better, because it makes you feel like you're in control of something that's absolutely uncontrollable. I wish I could help every single patient and make everything better, but patients really need to do that for themselves, as well. They're their biggest advocates. And as much as I advocate for everybody, it's not as easy said than done. With clinical trials, if you have not participated in one or you're a patient listening, I would just look into some information. You can ask your doctors. You can ask nurses that you regularly see. Usually they're available at larger institutions. If you're not near a large institution or that's not as accessible, there can still be options with that.

They really do change lives and not all of them are successful and become FDA-approved drugs. However, I still think there is value in participating in a trial, even if that's not the case, because one, you can get that medical care. And two, you form this relationship with staff that I think is instrumental to learning and being successful in coping with this disease on your own, because patients they come into the hospital for treatment and we expect them to be competent and know everything once they're discharged. Know how to manage their care outside of the hospital and mix their medications if you're on Prostacyclin, and that's not realistic. You have to have other ways of learning. You have to have mentors. You have to have people that are in your corner and supporting you. We can definitely be those people for patient. I really need patience to be those people for themselves sometimes, too. I want to support them and make everything better, but being able to learn and be a sponge is going to just change your life. We have so many different patients that either do well or they don't. There's no common denominator between all of them, but I really do think if you're always open to learning and really want to learn consistently and take charge of your care, you're going to do as well as you can. And we can definitely make that possible, especially with trials.

Sandeep Sahay, MD: I hope this helps our patients understand about the clinical trials a little bit more, and I am Dr. Sandeep Sahay.

Jordin Rice, RN: And I am Jordin Rice. And I'm aware that our patients are rare.

Listen and View more on the official phaware™ podcast site

#pulmonary hypertension #phaware #rare disease #lung disease #clinical trials #podcast #PH #asthma

0 notes

sunresearch · 1 year ago

Text

Paid Clinical Trials For Type 2 Diabetes

Embark on a transformative health journey with Sun Research Institute's Paid Clinical Trials for Type 2 Diabetes. As a participant, you contribute to pioneering research while gaining access to cutting-edge treatments. Our expert team ensures a comprehensive and patient-centric approach, prioritizing your well-being. Receive compensation for your valuable time and make a meaningful impact on the future of diabetes management. Join us in the pursuit of advancements that can revolutionize the way we understand and treat Type 2 Diabetes. Your involvement matters, and your health is our priority at Sun Research Institute.

#Diabetes Research And Clinical Practice #Paid Clinical Trials For Type 2 Diabetes #paid clinical trials in texas #clinical trials san antonio tx

0 notes

orbemnews · 4 years ago

Link

This New Covid Vaccine Could Bring Hope to the Unvaccinated World In early 2020, dozens of scientific teams scrambled to make a vaccine for Covid-19. Some chose tried-and-true techniques, such as making vaccines from killed viruses. But a handful of companies bet on a riskier method, one that had never produced a licensed vaccine: deploying a genetic molecule called RNA. The bet paid off. The first two vaccines to emerge successfully out of clinical trials, made by Pfizer-BioNTech and by Moderna, were both made of RNA. They both turned out to have efficacy rates about as good as a vaccine could get. In the months that followed, those two RNA vaccines have provided protection to tens of millions of people in some 90 countries. But many parts of the world, including those with climbing death tolls, have had little access to them, in part because they require being kept in a deep freeze. Now a third RNA vaccine may help meet that global need. A small German company called CureVac is on the cusp of announcing the results of its late-stage clinical trial. As early as next week, the world may learn whether its vaccine is safe and effective. CureVac’s product belongs to what many scientists refer to as the second wave of Covid-19 vaccines that could collectively ease the world’s demand. Novavax, a company based in Maryland whose vaccine uses coronavirus proteins, is expected to apply for U.S. authorization in the next few weeks. In India, the pharmaceutical company Biological E is testing another protein-based vaccine that was developed by researchers in Texas. In Brazil, Mexico, Thailand and Vietnam, researchers are starting trials for a Covid-19 shot that can be mass-produced in chicken eggs. Vaccines experts are particularly curious to see CureVac’s results, because its shot has an important advantage over the other RNA vaccines from Moderna and Pfizer-BioNTech. While those two vaccines have to be kept in a deep freezer, CureVac’s vaccine stays stable in a refrigerator — meaning it could more easily deliver the newly discovered power of RNA vaccines to hard-hit parts of the world. “It’s gone largely under the radar,” said Jacob Kirkegaard, a senior fellow at the Peterson Institute for International Economics in Washington, D.C. But now, he added, “they look pretty well positioned to clean up the global market.” For CureVac’s co-founder, the biologist Ingmar Hoerr, the company’s Covid-19 vaccine trial is the culmination of a quarter-century’s worth of work with RNA, a molecule that helps turn DNA into the proteins that do the work of our cells. As a graduate student at the University of Tübingen in the 1990s, Dr. Hoerr injected RNA into mice and found that the animals could make the protein encoded by the molecules. He was surprised to find that the mice’s immune systems made antibodies against the new proteins. Here, Dr. Hoerr thought, might be the basis for a new kind of vaccine. “I was thinking, Wow, if this works like that in humans, then we have a completely new pharmaceutical possibility,” he said. At the time, only a few scientists in the world considered an RNA vaccine a serious possibility. But proponents thought it might change medicine. You could, in theory, craft an RNA molecule to immunize people against any virus. You might even be able to create an RNA vaccine to cure cancer, if you could make an RNA molecule that encoded a tumor protein. In 2001, Dr. Hoerr co-founded CureVac to chase the idea, but for the first few years the company struggled to survive. To keep the lights on, it took orders from other labs for custom-built RNA molecules. On the side, CureVac’s scientists tinkered with their own designs for RNA vaccines. Over time, they found subtle tweaks to RNA vaccine molecules that caused cells to make more proteins. The more potent the RNA, the lower the dose they needed in vaccines. CureVac’s researchers also figured out how to put the RNA molecules in fatty bubbles to protect them from destruction on their journey to cells. And perhaps most important, they used a form of RNA that could stay stable at relatively warm temperatures. Instead of requiring a deep freezer, CureVac’s vaccine could be refrigerated. In time, other companies entered the RNA vaccine business as well: BioNTech in Germany in 2008, then Moderna in Boston in 2011. Their experiments began showing that these vaccines could protect animals against an assortment of viruses. In 2013, CureVac injected human volunteers with a rabies RNA vaccine, in the first clinical trial of the technology against an infectious disease. For years, CureVac and other RNA vaccine companies toiled on perfecting their vaccines. CureVac’s first attempt at a rabies vaccine demonstrated it was safe, but it yielded a weak response from the immune system. The company has since retooled that vaccine, and the updated version has shown promise in early clinical studies. But other efforts ended in failure. In 2017, CureVac announced that its RNA vaccine against prostate cancer offered no benefits to patients. Despite these setbacks, the company earned a solid reputation. “They ticked the boxes for scientific acumen, speed, scale and access,” said Nicholas Jackson, the head of vaccine research and development at the Coalition for Epidemic Preparedness Innovations, a foundation that supports vaccine research. C.E.P.I. gave $34 million to CureVac in 2019 to support its development of RNA vaccines for future pandemics. Updated May 5, 2021, 8:36 a.m. ET When the coronavirus pandemic hit, CureVac, BioNTech and Moderna all jumped in to make RNA vaccines. But BioNTech and Moderna soon pulled ahead, thanks in part to deep-pocketed allies. BioNTech teamed up with the pharmaceutical giant Pfizer, while Moderna worked with the National Institutes of Health and received a billion dollars from the U.S. government as part of Operation Warp Speed. CureVac lagged behind. C.E.P.I. provided the company with $15 million, but CureVac would require far more. “If you do this, you need a considerable amount of cash,” Franz-Werner Haas, the chief executive of CureVac, said in an interview. “And the considerable amount of cash was not there.” In March 2020, German newspapers reported that President Donald J. Trump had offered CureVac $1 billion to move its operations to the United States. CureVac denied the reports, but the chief executive suddenly left, to be replaced by Dr. Haas. CureVac’s researchers moved ahead with their limited resources, designing an RNA molecule encoding a protein found on the surface of the coronavirus, called spike. Experiments on hamsters showed that it could protect the animals from the virus. In June, the German government invested 300 million euros (about $360 million) in CureVac’s Covid-19 research, and other investors soon followed. In December, after promising data from early safety studies, the company started its final, so-called Phase 3 trial, recruiting 40,000 volunteers in Europe and Latin America. The company will get its first look at the data when 56 volunteers develop Covid-19. If most of them are in the placebo group, and few in the vaccinated group, it will be proof that the vaccine works. Dr. Haas said he expected to have that data by mid-May. There is no way to know in advance how CureVac will fare. But given the performance of other RNA vaccines, along with CureVac’s own early results, some scientists have high expectations. “I would just be really surprised if it didn’t work well,” said John Moore, a virologist at Weill Cornell Medicine in New York who has collaborated with CureVac on an RNA-based vaccine for H.I.V. Still, CureVac’s vaccine is facing a challenge that Pfizer and Moderna didn’t have: new variants that may be able to blunt its effectiveness. Experiments in mice have suggested that the vaccine works well against the B.1.351 variant, which first emerged in South Africa. Last year, CureVac partnered with a number of large companies to scale up production of its Covid vaccine, in case its clinical trials turned out well. The company also negotiated a deal with the European Union for 225 million doses, as well as an option to add another 180 million doses in subsequent months. But now it is not clear who might receive the CureVac vaccine if it becomes available next month. In January, the European Union gave emergency authorization to a vaccine from AstraZeneca, planning to rely on that company for most of its supply. But AstraZeneca fell drastically short of its supply promises, prompting the bloc to retaliate with a lawsuit. In April, the European Union finally fixed this shortfall, negotiating with Pfizer and BioNTech to get 1.8 billion doses of their vaccine between now and 2023. That arrangement has left analysts wondering how much demand will be left for CureVac. “They’re going to miss the boat on the major, advanced-economy markets,” said Dr. Kirkegaard. “The U.S., Europe and Japan are going to be largely vaccinated using these Moderna and Pfizer vaccines.” Dr. Haas countered that most of the bloc’s doses from Pfizer-BioNTech won’t come until next year. “CureVac sees itself as a major player in ending the Covid-19 pandemic in Europe and elsewhere,” he said. Ursula von der Leyen, president of the European Commission, said that if the CureVac vaccine worked, it would be in the mix, thanks to two advantages: It is an mRNA vaccine, and it was created in Europe. It is also possible that individual European nations will make side deals with the company. Billions of other people in low- and middle-income countries have yet to receive a vaccine, and experts say that CureVac may meet some of their demand. “We still need a lot of vaccine globally,” said Florian Krammer, a virologist at the Icahn School of Medicine at Mount Sinai in New York. “I think a lot of people can benefit from it.” The vaccines from Moderna and Pfizer-BioNTech are challenging to distribute in the developing world because of the equipment and power supply required to freeze these vaccines. CureVac’s RNA vaccine can stay stable for at least three months at 41 degrees Fahrenheit, and it can sit for 24 hours at room temperature before it is used. “The stability is a real advantage,” Dr. Jackson said. C.E.P.I. is “in very active discussions” with CureVac, he said, about distributing the company’s vaccine through Covax, an initiative to distribute vaccines to low- and middle-income countries. But CureVac is also designing a new generation of vaccines with a goal of eventually moving into markets in the United States and other wealthy nations. Because its potent RNA requires only a small dose, the company could potentially create vaccines for different variants and mix them in a single shot. But such possibilities are meaningless until CureVac can prove that its vaccine works. Mary Warrell, a vaccine researcher at the University of Oxford, is reluctant to speculate about the fate of the vaccine before that milestone. “Prediction during this pandemic has rarely been profitable,” she warned. Matina Stevis-Gridneff contributed reporting. Source link Orbem News #bring #Covid #Hope #unvaccinated #Vaccine #World

0 notes

boyprincessmanic · 7 years ago

Text

I’m putting the entire interview I had with this scam company under the cut. I’ve redacted personal information but I just want you guys to see what happened cuz it’s pretty wild lmao

For reference, they said they found me on Zip Recruiter but the company IMCheck Therapeutics is NOT on Zip Recruiter AT ALL that I could find.

This is a long post so be prepared lol

Me: Ms. Olivia Walter? This is Tory LastName.

Them: How are you doing today ?

Me: I'm doing well, how are you?

Them: I'm doing just fine.Thanks for asking I believe you are ready for the interview and briefing on the job position ?

Me: I am! I would like to know more about the company. Them: Before we begin i would like to introduce myself am Ms Olivia Walter, One of the hiring manager of ImCheck Therapeutics. I would be the one to brief you about the position and the Organization.

Kindly state your full name and your current location ?

Me: My name is FirstName (preferred name Tory) LastName and I'm located in [City], Texas.

Them: Next would be the briefing about the Job and the company. I advise you read with care.Let me know when you have finished reading and understanding every line. You will be allowed to ask questions later.With each line just respond with an OK..Understood?

Me: ok

Them: Once again the name of this Great Firm is ImCheck Therapeutics.

ImCheck Therapeutics is a Marseille-based, privately-held company developing next generation immuno-modulatory antibodies acting on both adaptive and innate immunity (notably gamma-delta T-cells) for the treatment of cancer and other immune related diseases.

With a “precision medicine-based” translational approach and several established academic collaborations, ImCheck is uniquely positioned to develop the right therapy for each patient.

To-date, ImCheck is developing two first-in-class therapeutic antibodies with a plan to enter into clinical trials by 2019. Imcheck is also advancing additional discovery programs on undisclosed targets.

Me: OK

Them: Here's the company website(www.imchecktherapeutics.com). You are required to glance through the website and read more about the organization. let me know as soon as you are done so we can proceed with the interview..Okay ?

Me: OK

Them: Are you still going through the company's website ?

Me: I have been reading it multiple times so I can fully understand.

Them: Alright.Let me know when you are done.

Me: I'm ready. I think I understand.

Them: Alright Before we get started with the interview session i would like to know if you have any question at this moment.

Me: I understand the company is based in France. Are there any offices where I'm located in [City] or is this a work-from-home position?

Them: Our office close to you will be completed estimated three months from now, so the position and job done for now is work from home on till the office is completed and (NOTE THAT) As soon as you are confirmed qualified, the company will provide you with complete office equipment to setup a mini office at home. The working hours are flexible and you can choose to work from anywhere of your choice, the pay is $40 per hour during full working hours and the training is $30 per hour and will be getting your payment weekly via check or direct deposit working 30 to 40 hours weekly, if you are employed you are going to be working as a full employee and not an independent contractor. Okay ?

Me: OK

Them: Our goal is to always have the capacity, competence and flexibility to meet our clients' needs, whatever they may be. The positions available are: Guest service representative. Administrative Assistant, IT business analyst, software engineering, Book keeping, Clerical Admin, Credit Correspondent, Customer Service, Data Entry,administrators,Secretary,Patient Access Specialist, Call Center, Office Clerk, GIs Analyst, Phone Representative, Executive Assistant, Finance and Accounting, Medical Biller/Coding, Order processing official, Project Development, Receptionist and Front desk job to create employment opportunity for the less privilege, disables and mainly to decrease the rate of unemployment in the economy. I want you to know that before you begin work, you would be trained towards it. So Which position do you prefer ?

Me: Data Entry

Them: Here are your duties as a DATA ENTRY ANALYST :

Prepares source data for computer entry by compiling and sorting information; establishing entry priorities.

Processes customer and account source documents by reviewing data for deficiencies; resolving discrepancies by using standard procedures or returning incomplete documents to the team leader for resolution.

Enters customer and account data by inputting alphabetic and numeric information on keyboard or optical scanner according to screen format.

Maintains data entry requirements by following data program techniques and procedures.

Verifies entered customer and account data by reviewing, correcting, deleting, or reentering data; combining data from both systems when account information is incomplete; purging files to eliminate duplication of data.

Can you handle the Job duties if you are being trained towards it ?

Me: Yes! With my experience I believe I can handle the position.

Them: Impressive. Here are the benefits: Health, Dental, Life and AD&D Insurance, Employee Wellness. Paid Time Off and Holidays with Generous Company Discounts.You would be eligible to Benefits after 1months of working with the organization.

You would be eligible to these benefits after 1month of working with the company. Endorsement benefit deals opportunity are available as well.

I hope you are okay with those benefits the company are offering?

Me: Yes, absolutely.

Them: Alright This section of the interview is called question and answer section.I advice you read with care to avoid any mistake...Okay ?

Me: OK

Have you ever worked from home or online before ?Are you currently employed ?How many hours do you intend to dedicate to this job position daily?

Me: At my previous job, I was occasionally required to work from home, and I perform well when I do. I was very recently laid off from my position due to much of my duties being automated, so currently I am unemployed. If hired, I intend to dedicate 8 hours a day to this position, or more if necessary to complete my tasks.

Them: OK Whats your clerical speed? Do you have an idea of how to use MS excel ?What is your highest educational diploma?When did you receive it?

Me: If by clerical speed you mean typing speed, I top out at 80 words per minute, 70 on average, with 98% accuracy. At my previous position I was required to use Microsoft Excel daily so I believe I am proficient in its use. My highest level of education is a General Educational Development (GED) diploma, which I obtained in 2012.

Them: Alright What are your strengths/What are your weaknesses?

Me: I pride my strengths in attention to detail, accuracy, and a genuinely love for being as thorough as possible in my work. As for weaknesses, I have difficulty focusing at times, due to what I believe is Adult ADHD, but I work to improve myself every day and always meet deadlines.

Them: Good to know. 4)How long do you expect to remain employed with this company if hired?

4B).How hard working and productive will you be for our company when you start working with us ?

4C). Are you a people person?

Me: I intend to remain employed for as long as possible. I enjoy computer work and I know how reliable I am. I will always, from the very beginning, deliver the best quality work I can provide and do the best I can for the company. I work very well with other people, be they co-workers or clients, and people know that they can trust me.

Them: Interesting. 5)How would you like to be Paid. Weekly Or Bi-Weekly?

5B).Are you seeking for a Full time or Part time position?.

5C). Do you have legal right to work in the United State ?

Me: I have no preference for when I am paid, but I suppose if I had to choose one I am accustomed to a bi-weekly pay schedule. Ideally, I am seeking a full-time position, and yes, I absolutely do have legal right to work in the United States.

Them: Good. 6)This company do pay employees via Direct Deposit or CHECK. Do you have an issue with getting paid via Direct Deposits or check?

What Bank Do you Operate with to see if it tallies with the company's official salary payment account and how many years have you been with them ?

Me: I have no issues with either option. My account is with [BANK], and I've banked with them since 2011.

Them: OK 7A).Kindly brief me about yourself and your last job?

7B).Do you use AT&T or Verizon,it will be linked with the company's postpaid account so we can cover the cost of the internet you'll be using ?

Me: My previous job was for a credit repair company called [COMPANY NAME], where I was hired in July 2015 to compare reports and update the database. Within 3 months I had proven myself enough that they chose to give me additional responsibilities, such as creating letters on our clients' behalf, and within the next 6 months I was given a promotion to supervisor level. During my time there I maintained a small team of people whom I helped train in our work program and distribute duties accordingly. Thanks to my nearly 3 years of experience at this position, I'm confident in my Data Entry abilities.

I, unfortunately, do not use AT&T or Verizon. My internet provider is Spectrum.

Them: Interesting. Well you have done well so far and you seem like a perfect fit for this position. Hold online while i send your answers to my superiors for review and consideration... okay ?

Me: Okay!

[About 15 minutes later] Them: I am back now..the result for the interview is on my desk..

Me: I hope it's good news.

Them: Tory for your consideration stand,You have a good news........................... The good news is.........You've just been confirmed qualified for this position of a DATA ENTRY ANALYST..You are welcome to ImCheck Therapeutics... You are now given a chance to show your commitment,charisma,diligence and be a productive employee.

CONGRATULATIONS !

Me: Thank you!

Them: Your employment letter will be emailed to you tomorrow morning,as soon as your working equipments are available, My superior's will reach you in person they will put you through our organization's guidelines under US Human Resources Laws and Regulations.OKAY ?

Me: Okay!

Them: NOTE: Your salary will be $40 per hour and you will be receiving your payment via direct deposit or check.

You will be undergoing a 3 days training and orientation which will commence as soon as you have all working materials,Your training is going to be done online through your PC and phone and you are rest assured that you will be paid for it.. okay ?

Me: Okay!

Them: I need you to provide the following info for confirmation Full name,state,zipcode,home address,email address,city,cell numbers and email address to enable my secretary enlist them into the Company's Register for proper documentation.

Me: [I gave them my address because I figured if they’d seen my resume they were just asking for confirmation]

Them: Alright.Your info's has been enlisted and updated.

Pay attention to this important details..When you are done reading signify by using DONE ,you will be allowed to ask questions when am done..okay?

Me: Okay

Them: You will need some Data entry/Accounting software and also a time tracker to commence your training and orientation and also you need the software to get started with work...the work of the time tracker is to calculate your hours worked since this is an online work from home.

Here are the name's of the software's you will need to start working with BS 1 Accounting software ,myob business essentials software 2017,For Peach Tree premium 2012 US Patent Single Users Pack, simply accounting 2012 and a Time Tracker

The Organization will provide you a free Hp laptop with a fast internet connection and your W4 form will be coming along with the working materials you need to start working with.

Me: Done

Them: The funds for the software and the Hp laptop will be provided for you by the organization via check ..... make sure you use them as instructed for the software.When the funds gets to you i will refer you to the company's authorized vendor you are to purchase them from As soon as the check its been issued out to you i will notify you and provide you with the tracking number so you can keep track and know when it will get to you..

Me: Okay

Them: Once you receive the check you are needed to have it deposited into your account via the ATM,inside the bank or using the Bank Mobile App,Then the funds will be made available in your account for cash out within 24hours..Then i will provide you the company's vendor information which you are to make the payment to so your working materials can be made available to you..

All we need from you is good work and trust,you will enjoy every moment working with us.

Me: Okay

Them: This Job offers Flexible hours but you are to report online via GOOGLE HANGOUT by 8am for your task and update on the paycheck you are expecting which is meant for the purchase of your working materials.....

Do you think 8am is a perfect time for you to report online ?

Me: Yes

Them: Alright. Once again Welcome to ImCheck Therapeutics..

Me: Thank you

Them: Thats all for now.Your employment letter will be emailed to you tomorrow morning. Do not forget to report online tomorrow at 8am for update on your upcoming check which is meant for the purchase of your working materials so you can begin work.Stay Blessed.

Me: Before you go, I have to admit I'm a little bit skeptical. Can you assure me that this is a legitimate offer?

Them: I understand how you feel.I can assure you that you are very safe working with us.Like i said as soon as your working equipments are available, My superior's will reach you in person they will put you through our organization's guidelines.All we need from you is good work and trust,you will enjoy every moment working with us..Okay ?

Me: Okay. Thank you very much

Them: I will keep you updated tomorrow at 8am via google hangout here.Have a wonderful time.

[After this conversation I began to feel very suspicious of this company. It felt like a scam, so I talked to a couple friends, both my parents, and my mom’s boyfriend, and they all gave me some advice on what to do next]

--- THE NEXT DAY ---

Them: Good morning Tory

Me: Good morning Olivia

Them: How are you doing today ?

Me: I'm doing just fine, how are you?

Them: I'm doing just fine.Thanks for asking.I believe you are ready for today's update ?

Me: I am. I also have a few questions for you as well when you are able to answer.

Them: You can ask your question now.

Me: Yesterday you told me that there is an office in [City] opening within 3 months or so. Where is the [City] office going to be located? Is there an address?

Them: I want you to know that the company's superiors are still delegating on a perfect location for the new office close to you in (City, TX),just to make transportation very easy for newly employed staff.As soon as the delegation is completed i will notify and provide you update on the location.The working hours are flexible and you have the chance to choose your working hours.Okay ?

Me: Do you know if the office is going to be a rented space? Is the company building a new office?

Them: The company is building a new place not rented.The address will be available after you have your working materials.Okay ?

Me: Is [City] the only city in the US that you're expanding to?

Them: Yes there are few other cities.The company's aim is to create employment opportunity for the less privilege, disables and mainly to decrease the rate of unemployment in the economy.Okay ?

Me: Are you partnered with a realtor for opening offices in [City]?

Them: The company has already take care of that,as soon as your working equipments are available, My superior's will reach you in person they will put you through our organization's guidelines.Okay ?

Me: Can you tell me what realtor you are working with for the office?

Them: That is not my department am in charge of the hiring process.Like i just said as soon as your working equipments are available, My superior's will reach you in person they will put you through our organization's guidelines.

Me: Just one more question for now. Would you be willing to do a video call or voice call? Would any of your superiors be willing to do this?

Them: Yes correct there will be a video call after you have your working materials just to confirm you have the complete working materials.

Me: Is there any way I could do a call before I begin work?

Them: Yes that will be when you have your working materials before you begin work.

Me: Is there any way I could do a call before I have the materials? As early as today if possible.

Them: I can see you are not ready to work.

Me: I apologize if I seem rude, I am trying to be as cautious as possible.

Them: I understand how you feel.I can assure you that you are very safe working with us.All we need from you is good work and trust,you will enjoy every moment working with us. [THIS IS THE EXACT SAME RESPONSE FROM YESTERDAY, COPIED WORD-FOR-WORD]

Me: Lastly, I had some trouble verifying some of the information you've given me, so I contacted IMCheck Therapeutics through the company website. Please understand my caution. I cannot proceed with giving you my personal information until I have verified the information. If what you have told me is true then you have nothing to worry about. Thank you for your patience.

THERE WAS NO RESPONSE AFTER THIS. This was definitely a scam and I have #regerts but at least I know now.

#personal

2 notes · View notes

ericvick · 4 years ago

Photo

Stocks Pare Losses, Bonds Hold Post-Powell Decline: Markets Wrap

Bloomberg

German Cases Hit Highest in a Month; Tokyo Extends: Virus Update

(Bloomberg) — Germany reported the largest rise in new Covid-19 cases in a month as the country grapples with the spread of mutations. Japan recommended extending its virus state of emergency by two weeks for the Tokyo region set to expire Sunday to prevent a fresh wave of infections as the nation prepares to host the Olympic games in July.China set a conservative economic growth target of above 6% for the year, outlining fiscal support with prudent monetary policy as a recovery takes hold. The U.S. Congressional Budget Office gave the green light for the Senate’s version of the pandemic-relief plan as debate is set to start with leaders eyeing a March 14 deadline.More than a dozen U.S. states reported increases in hospitalizations for the coronavirus, threatening to reverse a national trend that has pushed in-patient numbers to the lowest level since the fall. At the same time, governors across U.S. states, led by Texas, are loosening or abandoning social restrictions all together, counting on vaccines to usher in a return to pre-pandemic life.Key Developments:Global Tracker: Cases pass 115.6 million; deaths exceed 2.5 millionVaccine Tracker: More than 279 million shots given worldwideU.S. Spotlight: Hospitalizations in New York remain highest in nationInside Pfizer’s fast, fraught and lucrative vaccine distributionVaccinated workers get more office benefits than holdoutsWhere we are in hunting for the origin of Covid-19Subscribe to a daily update on the virus from Bloomberg’s Prognosis team here. Click CVID on the terminal for global data on cases and deaths.S. Korea Approves Pfizer Vaccine (2:31 p.m. HK)South Korea’s Ministry of Food and Drug Safety approved the use of Pfizer’s coronavirus vaccine under the condition that it submits results of final clinical trials, according to a statement.Takeda Files for Japan Approval of Moderna Vaccine (2:28 p.m. HK)Takeda Pharmaceutical Co. submitted an application to Japan’s Health Ministry to seek an approval for the use of Moderna’s Covid-19 vaccine.Some 50 million doses of Moderna’s vaccine are expected to be distributed beginning in the first half of this year. Results of a phase 1/2 trial it’s conducting in Japan are expected to be available in May and will be submitted to the Japan Pharmaceuticals and Medical Devices Agency. German Cases Rise to Highest in a Month (2:24 p.m. HK)The number of new cases in Germany rose by 11,393 in the 24 hours through Friday morning, according to data from Johns Hopkins University. That’s the biggest increase since Feb. 5.Germany’s health authority warned in a daily situation report that ��due to the occurrence of different virus variants, there is an increased risk of a renewed stronger increase in the number of cases.”Vietnam to Start Vaccinations on March 8 (1:38 p.m. HK)Vietnam will begin Covid-19 vaccinations on Monday, the news website VnExpress reported, citing Health Ministry Nguyen Thanh Long during a morning meeting of the anti-virus task force.The first shots of more than 117,600 AstraZeneca Plc doses are expected to be given to medical staff at 18 hospitals treating virus patients in 13 provinces and cities, VnExpress reported.China Seeks to Beef Up Biosecurity Labs (1:37 p.m. HK)China plans to ramp up the construction and management of biosecurity labs to prepare for future emerging diseases, while it also grapples with allegations from the U.S. that the coronavirus outbreak could have resulted from a lab leak.The country seeks to “comprehensively enhance biosecurity governance capabilities” by improving its monitoring and emergence preparedness, according to a document outlining major policy priorities through 2025Tokyo Targets 140 Daily Cases to Lift Emergency (12:26 p.m. HK)The Tokyo Metropolitan Government aims to bring daily coronavirus infections down to a 7-day average of about 140 before lifting the state of emergency in the capital, Nikkei reports, citing an unidentified person.Infections by that measure are about 269 now and the government is also aiming to lower hospitalized patients to about 1,000 from the current 1,519.Hong Kong Vaccination Rate Dips a Second Day (12:08 p.m. HK)Hong Kong has seen vaccination rates in the city decline for two straight days, in a sign the government may face difficulties keeping up the momentum of the inoculation program.The city administered vaccines to 10,300 people on Thursday, 12% lower than Wednesday’s rate, which itself was a 10% drop from the previous day. Tuesday’s total of 13,000 was the largest number of vaccinations since Hong Kong began giving shots to the public at the end of February.Auckland to Exit Lockdown on Sunday (12:07 p.m. HK)Auckland, New Zealand’s largest city, will exit a seven-day lockdown this weekend after a small community outbreak of Covid-19 was contained, Prime Minister Jacinda Ardern said.Auckland’s alert level will drop to 2 from 3 at 6 a.m. local time Sunday, allowing schools and businesses to reopen, Ardern said after a cabinet meeting Friday in Wellington. The remainder of New Zealand will move to level 1, meaning people no longer have to observe social distancing or limit the size of gatherings.Australia Downplays Italy’s Vaccine Block (12:06 p.m. HK)Australia’s health minister, Greg Hunt, downplayed the impact of Italy blocking supplies of AstraZeneca vaccines even as the nation starts its rollout.The company had a “deep, broad, global supply chain,” Hunt said. Still, Italy’s move was a reflection of “arguably the most intensely competitive international environment since, perhaps, the Second World War” as nations jostle to secure vaccines, masks and ventilators, Hunt told reporters.Australia began its rollout of the Pfizer/BioNTech Covid-19 vaccine about two weeks ago. It’s set to start domestic production of the AstraZeneca product, targeting 1 million doses a week from late March.California Extends Anti-Eviction Order (10:44 a.m. HK)Governor Gavin Newsom signed an executive order extending authorization for local governments to halt evictions for commercial renters impacted by the COVID-19 pandemic through June 30, 2021, according to a statement.The order extends protections against price gouging for emergency and medical supplies amid the ongoing response to the pandemic.Taiwan to Make 120 Million Doses by Yearend (10:42 a.m. HK)National Health Research Institutes will apply to build a second plant to expand vaccine production capacity, Taipei-based Apple Daily reported, citing Health Minister Chen Shih-chung.The government expects mass production of Taiwan’s Covid vaccines to start in July, the newspaper said.U.S. Hospitalizations Threaten to Rebound (9:08 a.m. HK)More than a dozen U.S. states reported increases in hospitalizations for the coronavirus, threatening to reverse a national trend that’s pushed in-patient numbers to the lowest level since the fall.U.S. hospitals were treating 49,519 patients as of Thursday, data from the Department of Health and Human Services show. The tally fell 3.8% since March 1 after California reported 544 fewer cases and Texas recorded a decline of 391. Hospitalizations are down 62% from a peak of 131,637 in mid-January, though the pace of the reduction appears to be slowing.Michigan had 945 hospitalizations Thursday, an increase of 13% over the past three days. Cases jumped 4.9% to 2,075 in Pennsylvania. New Jersey, Massachusetts, Connecticut, Rhode Island, Virginia, Tennessee, Utah, South Dakota, Montana, New Mexico, Nebraska, Idaho and Wyoming also recorded an increase in in-patients.Covid cases make up 12% of hospital patients in New York and Georgia, the highest proportion among U.S. states.Group Calls for Independent Virus Probe (9:05 a.m. HK)A group of scientists called for an independent probe to consider all hypotheses and nail down whether the virus came from an animal amid controversy over the investigation organized by the World Health Organization and China.More than 20 signatories said in an open letter published by the Wall Street Journal that the mission isn’t independent enough as the WHO considered delaying an interim report.Indonesia Holds Phase-3 Trial for China Vaccine (8:32 a.m. HK)A trial on the Covid-19 vaccine produced by China’s Anhui Zhifei Longkema Biological Pharmaceutical will enroll as many as 4,000 participants in Bandung and Jakarta, CNN Indonesia reports.Approval for an emergency use of the vaccine is expected in September, CNN reports.Wells Fargo Offers Vaccine Time Off (7:02 a.m. HK)Wells Fargo & Co., which has the largest workforce among U.S. banks, is encouraging employees to get vaccinated against Covid-19 and is offering paid time off for the inoculations.The firm will offer up to eight hours paid time off for employees across the world to get vaccinated, according to an internal memo reviewed by Bloomberg. The San Francisco-based bank is expanding a testing program, offering the service free to workers at its 25 largest locations, and those who work at other facilities can request an at-home test.Tokyo Plans to Extend Emergency (6:20 a.m. HK)The Japanese government recommended to extend by two weeks its virus state of emergency for the Tokyo region set to expire Sunday, trying to maintain a declining trend in infections as it looks to host the Olympics in about four months.The move was announced early Friday by the government’s point man for virus management, Economy Minister Yasutoshi Nishimura. It came after Prime Minister Yoshihide Suga strongly indicated Wednesday that he was looking to extend the nearly two-month measure, saying it was “an extremely important time for preventing infections.”Pfizer Plant Cited for Quality Issues (4:59 p.m. NY)The factory that Pfizer Inc. plans to use to boost production of its Covid-19 vaccine for the massive U.S. inoculation effort was cited by federal inspectors last year for repeated quality-control violations.Food and Drug Administration inspectors visited the McPherson, Kansas, plant at the end of 2019 into January 2020, according to an inspection report obtained by Bloomberg via a Freedom of Information request. They found the drug giant released medications for sale after failing to thoroughly review quality issues that arose in routine testing, the report shows.France Tightens Restrictions (1:20 p.m. NY)France plans to tighten restrictions and accelerate vaccinations in parts of the country as the government continues to shy away from a third nationwide lockdown on hopes that improvement is just weeks away.The Pas-de-Calais department on the northern coast of France will be put under a weekend lockdown as of Saturday, French Prime Minister Jean Castex said at a weekly news conference. “A lockdown, even limited to the weekend, is a heavy measure,” he said.Kuwait Imposes Curfew (12:53 p.m. NY)Kuwait has imposed a partial curfew as daily cases jumped to the highest on record. The curfew comes into force from March 7 between 5 a.m. and 5 p.m. for a month, the Council of Ministers said in a statement. The Gulf nation reported 1,716 new cases on Thursday, taking the total to 196,497 with 1,105 deaths.NYC Gets First J&J Vaccine Shots (11:05 a.m. NY)New York City has received 16,300 Johnson & Johnson vaccine doses, its first delivery of the one-shot vaccine, Mayor Bill de Blasio said. The city will use the J&J shots to begin vaccinating home-bound seniors, the mayor said in a Thursday briefing.De Blasio said when he becomes eligible to get the vaccine, he hopes to get the J&J shot. The city surpassed 2 million vaccinations this week and the city’s health commissioner has said vaccines may be available to all residents by late April.Zimbabwe Approves Indian Vaccine (11:02 a.m. NY)Zimbabwe has become the first African country to authorize the use of India’s only homegrown coronavirus vaccine, which the developers this week said showed strong efficacy.The first batch of Covaxin, which was co-developed by Hyderabad-based Bharat Biotech International Ltd. and the Indian Council of Medical Research, is due to arrive shortly, the Indian Embassy in the southern African nation said on its Twitter account.Germany, Sweden Clear Astra Shot for Elderly (7:44 a.m. NY)Germany has joined countries widening guidelines for AstraZeneca’s vaccine, based on incoming data that support giving the shot to the elderly.Germany’s immunization commission is recommending the vaccine for people age 65 and older, Health Minister Jens Spahn said in an emailed statement. That expands on a ruling that initially limited it to adults between the ages of 18 and 64.Sweden has lifted its recommendation against using AstraZeneca’s vaccine for people older than 65, Public Health Agency Official Sara Byfors told reporters.Milan Tightens Curbs (6:42 a.m. NY)Almost one year after Milan became the first European region to enter into a hard lockdown, the Italian financial capital is again facing major restrictions.All schools will be closed until March 14 and no person will be able to leave town if not for business and health reasons. Milan citizens won’t be allowed to reach their holiday houses, with bars and restaurants remaining closed while shops can stay open.For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.

#Bonds #decline #hold #Losses #markets #Pare #PostPowell #Stocks #Wrap

0 notes

newstfionline · 4 years ago

Text

Friday, February 12, 2021

House managers wrap up case against Trump (Washington Post) House managers on Thursday wrapped up their case against former president Donald Trump, imploring the Senate to convict him while warning that he could stoke violence again. Trump’s legal team is poised to respond on Friday, arguing that he should be acquitted. They are expected to use only one of two allotted days. A verdict could come as early as the weekend. The developments came on the third day of an impeachment trial in which Democrats have charged Trump with “incitement of insurrection” for his role in the Jan. 6 violent takeover of the Capitol.

California Is Making Liberals Squirm (NYT) California is a remarkable place. It also has the highest poverty rate in the nation, when you factor in housing costs, and vies for the top spot in income inequality, too. The median price for a home in California is more than $700,000. As Bloomberg reported in 2019, the state has four of the nation’s five most expensive housing markets and a quarter of the nation’s homeless residents. In much of San Francisco, you can’t walk 20 feet without seeing a multicolored sign declaring that Black lives matter, kindness is everything and no human being is illegal. Those signs sit in yards zoned for single families, in communities that organize against efforts to add the new homes that would bring those values closer to reality. Poorer families—disproportionately nonwhite and immigrant—are pushed into long commutes, overcrowded housing and homelessness. Those inequalities have turned deadly during the pandemic. There is a danger—not just in California, but everywhere—that politics becomes an aesthetic rather than a program. It’s a danger on the right, where Donald Trump modeled a presidency that cared more about retweets than bills. But it’s also a danger on the left, where the symbols of progressivism are often preferred to the sacrifices and risks those ideals demand.

6 killed in 130-vehicle pileup on icy Texas interstate (AP) A massive crash involving more than 130 vehicles on an icy Texas interstate left six people dead and dozens injured Thursday amid a winter storm that dropped freezing rain, sleet and snow on parts of the U.S. At the scene of the crash on Interstate 35 near downtown Fort Worth, a tangle of semitrailers, cars and trucks had smashed into each other and had turned every which way, with some vehicles on top of others. The ice storm came as a polar vortex — swirling air that normally sits over the Earth’s poles — has moved near the U.S.-Canada border, resulting in colder weather farther south than usual, said Steve Goss, a meteorologist with the National Weather Service’s Storm Prediction Center in Norman, Oklahoma.

History of abuse for Mexican police unit in migrant massacre (AP) When state police in northern Mexico allegedly shot 19 people, including at least 14 Guatemalan migrants, to death in late January near the border with Texas, it was a tragedy that critics say authorities had been warned could come. In 2019, prosecutors charged that the same Tamaulipas state police unit, then operating under a different name, pulled eight people from their homes in the border city of Nuevo Laredo, posed them in clothing and vehicles to make them look like criminals, and shot them to death. Now, a dozen officers of the 150-member Special Operations Group, known by its Spanish initials as GOPES, have been ordered held for trial on charges they shot to death at least 14 Guatemalan migrants and two Mexicans on a rural road in the border township of Camargo. The bodies were then set afire and burned so badly that three other corpses are still awaiting identification. Authorities had ample warning of the problems in the unit, which was created last year from the remains of the special forces group accused of the 2019 killings and other atrocities. A federal legislator even filed a non-binding resolution in Mexico’s Congress in early January to protest beatings and robberies by the unit. “If back then they had done something, if any attention had been paid, perhaps today we would not be mourning the deaths of 19 people,” said Marco Antonio Mariño, vice president of the Tamaulipas Federation of Business Chambers.

Brazilian ballerina born without arms soars with her attitude (Reuters) When Vitória Bueno’s mother first dropped her off at ballet class, she worried about her five-year-old fitting in. Born without arms, Bueno’s dream of being a dancer seemed painfully unrealistic—especially in a small town in rural Brazil. But Bueno, now 16, focused on her assemblés, pirouettes and other technical challenges. She took up jazz and tap as well. Now a regular at the ballet academy in her hometown in the state of Minas Gerais, Bueno’s talent has made her a social media star and an inspiration to many. Watching her glide across the wooden stage, synchronized with her colleagues in a dazzle of green and white, it is easy to forget she dances without arms. More than just realizing a dream, the strength and flexibility gained through dance have proven crucial to Bueno, who does everything from brushing her teeth to picking items off the supermarket shelf with her feet. “There are things she can do with her feet that I can’t do with my hands,” said her stepfather, Jose Carlos Perreira. With over 150,000 Instagram followers, Bueno is glad to be a role model for others too. “We are more than our disabilities, so we have to chase our dreams,” she said, flashing a broad smile.

German children suffer from psychological issues in pandemic (AP) A new survey of children in Germany suggests that the stress and depravations of the coronavirus pandemic are taking a toll on their mental health, especially among those from underprivileged families, researchers said Wednesday. The study by the University Medical Center Hamburg-Eppendorf found about one in three German children are suffering from pandemic-related anxiety, depression or are exhibiting psychosomatic symptoms like headaches or stomach aches. Children and teenagers from poorer families and those with migrant roots are disproportionally affected, according to the study. “Children who were doing well before the pandemic and feel sheltered and comfortable within their families will get through this pandemic well,” said Ulrike Ravens-Sieberer, the head of the study and research director of the children’s psychiatric clinic at the university hospital.

Koo d’etat (Foreign Policy) Indian lawmakers are threatening to abandon Twitter in favor of Indian lookalike app Koo amid a dispute with the Silicon Valley company. The Indian government has ordered the removal of hundreds of Twitter accounts and posts in recent days over claims that users are spreading misinformation about ongoing farmer protests. On Wednesday, Twitter announced it would not comply with some takedown orders as it deemed them in contravention of Indian law. India’s IT ministry posted its displeasure with Twitter on rival app Koo, as a number of Indian leaders, including Trade Minister Piyush Goyal encouraged a Twitter exodus. The Koo app has seen a ten-fold increase in downloads as a result of the spat—a total of 3 million in the past two days.

They were accused of plotting to overthrow the Modi government. The evidence was planted, a new report says. (Washington Post) Key evidence against a group of Indian activists accused of plotting to overthrow the government was planted on a laptop seized by police, a new forensics report concludes, deepening doubts about a case viewed as a test of the rule of law under Prime Minister Narendra Modi. An attacker used malware to infiltrate a laptop belonging to one of the activists, Rona Wilson, before his arrest and deposited at least 10 incriminating letters on the computer, according to a report from Arsenal Consulting, a Massachusetts-based digital forensics firm that examined an electronic copy of the laptop at the request of Wilson’s lawyers. Many of the activists have been jailed for more than two years without trial under a stringent anti-terrorism law. Human rights groups and legal experts consider the case an attempt to suppress dissent in India, where government critics have faced intimidation, harassment and arrest during Modi’s tenure. Sudeep Pasbola, a lawyer representing Wilson, said the Arsenal report proved his client’s innocence and “destabilizes” the prosecution case against the activists. On Wednesday, Wilson’s lawyers included the report in a petition filed in the High Court of Bombay urging judges to dismiss the case against their client.

China to pull BBC News off the air, state broadcast regulator says (Washington Post) China’s broadcasting regulator has moved to pull BBC News off the air in the country over a “serious content violation,” the Chinese state news agency Xinhua reported Thursday. China’s National Radio and Television Administration (NRTA) said in an announcement on its website that the broadcaster, which is partly funded by the British state but editorially independent, had “undermined China’s national interests and ethnic solidarity.” The announcement, which arrived with the Lunar New Year holiday in China, followed recent disputes between Chinese officials and BBC News. It also came just a week after Britain’s media regulator pulled the Chinese state-run television channel CGTN off British airwaves because of alleged errors in an application to transfer its license to another company. In December, BBC News produced a report that alleged the forced labor of ethnic minority Uighurs in China’s cotton industry in Xinjiang. Chinese state media bristled at the work, calling it “fake news” and accusing the BBC of political bias.

Racialized surveillance (Foreign Policy) Following numerous reports of Chinese firms, including Huawei, singling out Uighurs in facial recognition, a Los Angeles Times/IPVM investigation found that Dahua, the world’s second-largest security camera manufacturer, provides Chinese police with “real-time warning for Uighurs” and informs them of “Uighurs with hidden terrorist inclinations.” In many parts of China, being Uighur is now effectively criminalized, with the few remaining Uighur residents of cities outside Xinjiang reporting routine harassment by police. The arrival of Uighurs, even mothers with children, in a new city or town prompts the arrival of the police and actions ranging from warnings to stay in their hotel or apartment to deportation back to Xinjiang. Dahua is rolling out its race-based systems to other countries, which may have their own least favored minorities to target.

Biden Announces Myanmar Sanctions (Foreign Policy) U.S. President Joe Biden has announced U.S. sanctions against Myanmar’s military junta, ten days after the military seized absolute power and arrested members of the country’s democratically-elected leadership. Biden is to freeze $1 billion in Myanmar’s state assets held in U.S. banks, with further sanctions expected to follow against a “first round of targets” this week. But Myanmar’s generals have endured sanctions before—including recent ones over the ethnic cleansing of its Rohingya minority—and so whatever the international community can muster is unlikely to dislodge them.

Digital siege: Internet cuts become favored tool of regimes (AP) When army generals in Myanmar staged a coup last week, they briefly cut internet access in an apparent attempt to stymie protests. In Uganda, residents couldn’t use Facebook, Twitter and other social media for weeks after a recent election. And in Ethiopia’s northern Tigray region, the internet has been down for months amid a wider conflict. Around the world, shutting down the internet has become an increasingly popular tactic of repressive and authoritarian regimes and some illiberal democracies. Digital rights groups say governments use them to stifle dissent, silence opposition voices or cover up human rights abuses. Regimes often cut online access in response to protests or civil unrest, particularly around elections, as they try to keep their grip on power by restricting the flow of information, researchers say. Last year there were 93 major internet shutdowns in 21 countries, according to a report by Top10VPN, a U.K.-based digital privacy and security research group. The list doesn’t include places like China and North Korea, where the government tightly controls or restricts the internet.

Japan Olympics chief who said women talk too much will resign over remarks, reports say (Washington Post) The head of the Tokyo Olympics organizing committee is set to resign, Japanese media reported on Thursday, after an uproar over sexist remarks he had made about women at a meeting last week. Mori, an 83-year-old former prime minister with a record of insensitive and sexist pronouncements, had tried to justify the lack of women at a senior level in the Japanese Olympic Committee by saying women talk too much at meetings and make them run on too long. The following day he apologized but showed no apparent remorse and said he had no intention of resigning. The comments provoked an unprecedented reaction in Japan, with more than 146,000 people signing an online petition calling on him to step down. Nearly 500 Olympic volunteers withdrew, and one poll found less than 7 percent of respondents thought Mori was qualified to continue in his role. The World Economic Forum ranks Japan 121st out of 153 countries in terms of gender parity, with the largest gender gap among advanced economies.

20 UN peacekeepers injured in an attack in central Mali (AP) An attack on a United Nations base in central Mali has injured at least 20 peacekeepers, the U.N. mission spokesman said Wednesday. The temporary U.N. base in Kerena, near Douentza, was the target of direct and indirect fire early Wednesday morning, Olivier Salgado said in a statement on Twitter. No group has claimed responsibility for the attack, but Islamic extremists linked to al-Qaida and the Islamic State group stage regular attacks on U.N. peacekeepers and soldiers.

Salesforce declares the 9-to-5 workday dead, will let some employees work remotely from now on (The Verge) Cloud computing company Salesforce is joining other Silicon Valley tech giants in announcing a substantial shift in how it allows its employees to work. In a blog post published Tuesday, the company says the “9-to-5 workday is dead” and that it will allow employees to choose one of three categories that dictate how often, if ever, they return to the office once it’s safe to do so. The company joins other tech firms like Facebook and Microsoft that have announced permanent work-from-home policies in response to the coronavirus pandemic. “As we enter a new year, we must continue to go forward with agility, creativity and a beginner’s mind—and that includes how we cultivate our culture. An immersive workspace is no longer limited to a desk in our Towers; the 9-to-5 workday is dead; and the employee experience is about more than ping-pong tables and snacks,” writes Brent Hyder, Salesforce’s chief people officer. “In our always-on, always-connected world, it no longer makes sense to expect employees to work an eight-hour shift and do their jobs successfully,” Hyder adds. “Whether you have a global team to manage across time zones, a project-based role that is busier or slower depending on the season, or simply have to balance personal and professional obligations throughout the day, workers need flexibility to be successful.”

At first cat lawyer was embarrassed. Then he realized we all could use a laugh. (Washington Post) As far as courtroom disclosures go, this one was unique: “I’m not a cat,” a Texas attorney claimed as his Zoom square displayed a fluffy white feline. At a routine civil forfeiture case hearing in Texas’ 394th Judicial District Court, Presidio County attorney Rod Ponton accidentally signed on with the cat filter, making the flummoxed attorney look like an adorable kitten. The 34-second clip of Ponton’s brief appearance as a cat immediately amused many and is becoming a viral hit. The prevalence of video chat platforms for court appearances has led to other unusual moments: A defendant in Sacramento appeared from a barber’s chair, a Florida burglary suspect tried to flirt his way out of trouble with a judge, and a lawyer in Peru was caught on camera naked after he stripped to have sex. But Tuesday’s video was the cat’s pajamas to many. Even Ponton, once he recovered from cat face and mortification, found humor in his proverbial 15 minutes of fame. “At first I was worried about it,” Ponton, 69, told The Washington Post on Tuesday, “but then I realized as it was going viral if the country could take a moment to laugh at my cat moment at my expense, I’ll take it. We’ve had a stressful year.”

#headlines #news

0 notes

sunresearch · 1 year ago

Text

Embark on a journey of medical discovery with Atherosclerosis Clinical Trials at Sun Research Institute. We are at the forefront of groundbreaking research, dedicated to advancing cardiovascular health. By participating in our trials, you contribute to the development of innovative treatments and interventions. Experience personalized care, regular health assessments, and the potential for cutting-edge therapies. Join us in the pursuit of a healthier future, where your involvement not only benefits you but also plays a vital role in the global fight against atherosclerosis. Be a part of progress at Sun Research Institute today.

#clinical trials #atherosclerosis clinical trials #paid clinical trials in texas

0 notes

stephenmccull · 4 years ago

Text

Family Caregivers, Routinely Left Off Vaccine Lists, Worry What Would Happen ‘If I Get Sick’

Robin Davidson entered the lobby of Houston Methodist Hospital, where her 89-year-old father, Joe, was being treated for a flare-up of congestive heart failure.

This story also ran on CNN. It can be republished for free.

Before her stretched a line of people waiting to get covid-19 vaccines. “It was agonizing to know that I couldn’t get in that line,” said Davidson, 50, who is devoted to her father and usually cares for him full time. “If I get sick, what would happen to him?”

Tens of thousands of middle-aged sons and daughters caring for older relatives with serious ailments but too young to qualify for a vaccine themselves are similarly terrified of becoming ill and wondering when they can get protected against the coronavirus.

Like aides and other workers in nursing homes, these family caregivers routinely administer medications, monitor blood pressure, cook, clean and help relatives wash, get dressed and use the toilet, among many other responsibilities. But they do so in apartments and houses, not in long-term care institutions — and they’re not paid.

“In all but name, they’re essential health care workers, taking care of patients who are very sick, many of whom are completely reliant upon them, some of whom are dying,” said Katherine Ornstein, a caregiving expert and associate professor of geriatrics and palliative medicine at Mount Sinai’s medical school in New York City. “Yet, we don’t recognize or support them as such, and that’s a tragedy.”

The distinction is critically important because health care workers have been prioritized to get covid vaccines, along with vulnerable older adults in nursing homes and assisted living facilities. But family members caring for equally vulnerable seniors living in the community are grouped with the general population in most states and may not get vaccines for months.

The exception: Older caregivers can qualify for vaccines by virtue of their age as states approve vaccines for adults ages 65, 70 or 75 and above. A few states have moved family caregivers into phase 1a of their vaccine rollouts, the top priority tier. Notably, South Carolina has done so for families caring for medically fragile children, and Illinois has given that designation to families caring for relatives of all ages with significant disabilities.

Arizona is also trying to accommodate caregivers who accompany older residents to vaccination sites, Dr. Cara Christ, director of the state’s Department of Health Services, said Monday during a Zoom briefing for President Joe Biden. Comprehensive data about which states are granting priority status to family caregivers is not available.

Meanwhile, the Department of Veterans Affairs recently announced plans to offer vaccines to people participating in its Program of Comprehensive Assistance for Family Caregivers. That initiative gives financial stipends to family members caring for veterans with serious injuries; 21,612 veterans are enrolled, including 2,310 age 65 or older, according to the VA. Family members can be vaccinated when the veterans they look after become eligible, a spokesperson said.

“The current pandemic has amplified the importance of our caregivers whom we recognize as valuable members of Veterans’ health care teams,” Dr. Richard Stone, VA acting undersecretary for health, said in the announcement.

An estimated 53 million Americans are caregivers, according to a 2020 report. Nearly one-third spend 21 hours or more each week helping older adults and people with disabilities with personal care, household tasks and nursing-style care (giving injections, tending wounds, administering oxygen and more). An estimated 40% are providing high-intensity care, a measure of complicated, time-consuming caregiving demands.

This is the group that should be getting vaccines, not caregivers who live at a distance or who don’t provide direct, hands-on care, said Carol Levine, a senior fellow and former director of the Families and Health Care Project at the United Hospital Fund in New York City.

Rosanne Corcoran, 53, is among them. Her 92-year-old mother, Rose, who has advanced dementia, lives with Corcoran and her family in Collegeville, Pennsylvania, on the second floor of their house. She hasn’t come down the stairs in three years.

“I wouldn’t be able to take her somewhere to get the vaccine. She doesn’t have any stamina,” said Corcoran, who arranges for doctors to make house calls when her mother needs attention. When she called their medical practice recently, an administrator said they didn’t have access to the vaccines.

Corcoran said she “does everything for her mother,” including bathing her, dressing her, feeding her, giving her medications, monitoring her medical needs and responding to her emotional needs. Before the pandemic, a companion came for five hours a day, offering some relief. But last March, Corcoran let the companion go and took on all her mother’s care herself.

Corcoran wishes she could get a vaccination sooner, rather than later. “If I got sick, God forbid, my mother would wind up in a nursing home,” she said. “The thought of my mother having to leave here, where she knows she’s safe and loved, and go to a place like that makes me sick to my stomach.”

Although covid cases are dropping in nursing homes and assisted living facilities as residents and staff members receive vaccines, 36% of deaths during the pandemic have occurred in these settings.

Maggie Ornstein, 42, a caregiving expert who teaches at Sarah Lawrence College, has provided intensive care to her mother, Janet, since Janet experienced a devastating brain aneurism at age 49. For the past 20 years, her mother has lived with Ornstein and her family in Queens, New York.

In a recent opinion piece, Ornstein urged New York officials to recognize family caregivers’ contributions and reclassify them as essential workers. “We’re used to being abandoned by a system that should be helping us and our loved ones,” she told me in a phone conversation. “But the utter neglect of us during this pandemic — it’s shocking.”

Ornstein estimated that if even a quarter of New York’s 2.5 million family caregivers became ill with covid and unable to carry on, the state’s nursing homes would be overwhelmed by applications from desperate families. “We don’t have the infrastructure for this, and yet we’re pretending this problem just doesn’t exist,” she said.

In Tomball, Texas, Robin Davidson’s father was independent before the pandemic, but he began declining as he stopped going out and became more sedentary. For almost a year, Davidson has driven every day to his 11-acre ranch, 5 miles from where she lives, and spent hours tending to him and the property’s upkeep.

“Every day, when I would come in, I would wonder, was I careful enough [to avoid the virus]? Could I have picked something up at the store or getting gas? Am I going to be the reason that he dies? My constant proximity to him and my care for him is terrifying,” she said.

Since her father’s hospitalization, Davidson’s goal is to stabilize him so he can enroll in a clinical trial for congestive heart failure. Medications for that condition no longer work for him, and fluid retention has become a major issue. He’s now home on the ranch after spending more than a week in the hospital and he’s gotten two doses of vaccine — “an indescribable relief,” Davidson said.

Out of the blue, she got a text from the Harris County health department earlier this month, after putting herself on a vaccine waitlist. Vaccines were available, it read, and she quickly signed up and got a shot. Davidson ended up being eligible because she has two chronic medical conditions that raise her risk of covid; Harris County doesn’t officially recognize family caregivers in its vaccine allocation plan, a spokesperson said.

Kaiser Health News (KHN) is a national health policy news service. It is an editorially independent program of the Henry J. Kaiser Family Foundation which is not affiliated with Kaiser Permanente.

USE OUR CONTENT

This story can be republished for free (details).

Family Caregivers, Routinely Left Off Vaccine Lists, Worry What Would Happen ‘If I Get Sick’ published first on https://smartdrinkingweb.weebly.com/

0 notes

orbemnews · 4 years ago

Link

The Covid-19 Plasma Boom Is Over. What Did We Learn From It? Scott Cohen was on a ventilator struggling for his life with Covid-19 last April when his brothers pleaded with Plainview Hospital on Long Island to infuse him with the blood plasma of a recovered patient. The experimental treatment was hard to get but was gaining attention at a time when doctors had little else. After an online petition drew 18,000 signatures, the hospital gave Mr. Cohen, a retired Nassau County medic, an infusion of the pale yellow stuff that some called “liquid gold.” In those terrifying early months of the pandemic, the idea that antibody-rich plasma could save lives took on a life of its own before there was evidence that it worked. The Trump administration, buoyed by proponents at elite medical institutions, seized on plasma as a good-news story at a time when there weren’t many others. It awarded more than $800 million to entities involved in its collection and administration, and put Dr. Anthony S. Fauci’s face on billboards promoting the treatment. A coalition of companies and nonprofit groups, including the Mayo Clinic, Red Cross and Microsoft, mobilized to urge donations from people who had recovered from Covid-19, enlisting celebrities like Samuel L. Jackson and Dwayne Johnson, the actor known as the Rock. Volunteers, some dressed in superhero capes, showed up to blood banks in droves. Mr. Cohen, who later recovered, was one of them. He went on to donate his own plasma 11 times. But by the end of the year, good evidence for convalescent plasma had not materialized, prompting many prestigious medical centers to quietly abandon it. By February, with cases and hospitalizations dropping, demand dipped below what blood banks had stockpiled. In March, the New York Blood Center called Mr. Cohen to cancel his 12th appointment. It didn’t need any more plasma. A year ago, when Americans were dying of Covid at an alarming rate, the federal government made a big bet on plasma. No one knew if the treatment would work, but it seemed biologically plausible and safe, and there wasn’t much else to try. All told, more than 722,000 units of plasma were distributed to hospitals thanks to the federal program, which ends this month. The government’s bet did not result in a blockbuster treatment for Covid-19, or even a decent one. But it did give the country a real-time education in the pitfalls of testing a medical treatment in the middle of an emergency. Medical science is messy and slow. And when a treatment fails, which is often, it can be difficult for its strongest proponents to let it go. Because the government gave plasma to so many patients outside of a controlled clinical trial, it took a long time to measure its effectiveness. Eventually, studies did emerge to suggest that under the right conditions, plasma might help. But enough evidence has now accumulated to show that the country’s broad, costly plasma campaign had little effect, especially in people whose disease was advanced enough to land them in the hospital. In interviews, three federal health officials — Dr. Stephen M. Hahn, the former commissioner of the Food and Drug Administration; Dr. Peter Marks, a top F.D.A. regulator; and Dr. H. Clifford Lane, a clinical director at the National Institutes of Health — acknowledged that the evidence for plasma was limited. “The data are just not that strong, and it makes it makes it hard, I think, to be enthusiastic about seeing it continue to be used,” Dr. Lane said. The N.I.H. recently halted an outpatient trial of plasma because of a lack of benefit. Plasma promotions Doctors have used the antibodies of recovered patients as treatments for more than a century, for diseases including diphtheria, the 1918 flu and Ebola. So when patients began falling ill with the new coronavirus last year, doctors around the world turned to the old standby. In the United States, two hospitals — Mount Sinai in New York City and Houston Methodist in Texas — administered the first plasma units to Covid-19 patients within hours of each other on March 28. Dr. Nicole M. Bouvier, an infectious-disease doctor who helped set up Mount Sinai’s plasma program, said the hospital had tried the experimental treatment because blood transfusions carry a relatively low risk of harm. With a new virus spreading quickly, and no approved treatments, “nature is a much better manufacturer than we are,” she said. As Mount Sinai prepared to infuse patients with plasma, Diana Berrent, a photographer, was recovering from Covid-19 at her home in Port Washington, N.Y. Friends began sending her Mount Sinai’s call for donors. “I had no idea what plasma was — I haven’t taken a science class since high school,” Ms. Berrent recalled. But as she researched its history in previous disease outbreaks, she became fixated on how she could help. She formed a Facebook group of Covid-19 survivors that grew to more than 160,000 members and eventually became a health advocacy organization, Survivor Corps. She livestreamed her own donation sessions to the Facebook group, which in turn prompted more donations. “People were flying places to go donate plasma to each other,” she said. “It was really a beautiful thing to see.” Around the same time, Chaim Lebovits, a shoe wholesaler from Monsey, N.Y., in hard-hit Rockland County, was spreading the word about plasma within his Orthodox Jewish community. Mr. Lebovits called several rabbis he knew, and before long, thousands of Orthodox Jewish people were getting tested for coronavirus antibodies and showing up to donate. Coordinating it all was exhausting. “April,” Mr. Lebovits recalled with a laugh, “was like 20 decades.” Two developments that month further accelerated plasma’s use. With the help of $66 million in federal funding, the F.D.A. tapped the Mayo Clinic to run an expanded access program for hospitals across the country. And the government agreed to cover the administrative costs of collecting plasma, signing deals with the American Red Cross and America’s Blood Centers. The news releases announcing those deals got none of the flashy media attention that the billion-dollar contracts for Covid-19 vaccines did when they arrived later in the summer. And the government did not disclose how much it would be investing. That investment turned out to be significant. According to contract records, the U.S. government has paid $647 million to the American Red Cross and America’s Blood Centers since last April. “The convalescent plasma program was intended to meet an urgent need for a potential therapy early in the pandemic,” a health department spokeswoman said in a statement. “When these contracts began, treatments weren’t available for hospitalized Covid-19 patients.” Updated April 17, 2021, 10:17 a.m. ET As spring turned to summer, the Trump administration seized on plasma — as it had with the unproven drug hydroxychloroquine — as a promising solution. In July, the administration announced an $8 million advertising campaign “imploring Americans to donate their plasma and help save lives.” The blitz included promotional radio spots and billboards featuring Dr. Fauci and Dr. Hahn, the F.D.A. commissioner. A coalition to organize the collection of plasma was beginning to take shape, connecting researchers, federal officials, activists like Ms. Berrent and Mr. Lebovits, and major corporations like Microsoft and Anthem on regular calls that have continued to this day. Nonprofit blood banks and for-profit plasma collection companies also joined the collaboration, named the Fight Is In Us. The group also included the Mitre Corporation, a little-known nonprofit organization that had received a $37 million government grant to promote plasma donation around the country. The participants sometimes had conflicting interests. While the blood banks were collecting plasma to be immediately infused in hospitalized patients, the for-profit companies needed plasma donations to develop their own blood-based treatment for Covid-19. Donations at those companies’ own centers had also dropped off after national lockdowns. “They don’t all exactly get along,” Peter Lee, the corporate vice president of research and incubations at Microsoft, said at a virtual scientific forum in March organized by Scripps Research. Microsoft was recruited to develop a locator tool, embedded on the group’s website, for potential donors. But the company took on a broader role “as a neutral intermediary,” Dr. Lee said. The company also provided access to its advertising agency, which created the look and feel for the Fight Is In Us campaign, which included video testimonials from celebrities. Lack of evidence In August, the F.D.A. authorized plasma for emergency use under pressure from President Donald J. Trump, who had chastised federal scientists for moving too slowly. At a news conference, Dr. Hahn, the agency’s commissioner, substantially exaggerated the data, although he later corrected his remarks following criticism from the scientific community. In a recent interview, he said that Mr. Trump’s involvement in the plasma authorization had made the topic polarizing. “Any discussion one could have about the science and medicine behind it didn’t happen, because it became a political issue as opposed to a medical and scientific one,” Dr. Hahn said. The authorization did away with the Mayo Clinic system and opened access to even more hospitals. As Covid-19 cases, hospitalizations and deaths skyrocketed in the fall and winter, use of plasma did, too, according to national usage data provided by the Blood Centers of America. By January of this year, when the United States was averaging more than 130,000 hospitalizations a day, hospitals were administering 25,000 units of plasma per week. Many community hospitals serving lower-income patients, with few other options and plasma readily available, embraced the treatment. At the Integris Health system in Oklahoma, giving patients two units of plasma became standard practice between November and January. Dr. David Chansolme, the system’s medical director of infection prevention, acknowledged that studies of plasma had showed it was “more miss than hit,” but he said his hospitals last year lacked the resources of bigger institutions, including access to the antiviral drug remdesivir. Doctors with a flood of patients — many of them Hispanic and from rural communities — were desperate to treat them with anything they could that was safe, Dr. Chansolme said. By the fall, accumulating evidence was showing that plasma was not the miracle that some early boosters had believed it to be. In September, the Infectious Diseases Society of America recommended that plasma not be used in hospitalized patients outside of a clinical trial. (On Wednesday, the society restricted its advice further, saying plasma should not be used at all in hospitalized patients.) In January, a highly anticipated trial in Britain was halted early because there was not strong evidence of a benefit in hospitalized patients. In February, the F.D.A. narrowed the authorization for plasma so that it applied only to people who were early in the course of their disease or who couldn’t make their own antibodies. Dr. Marks, the F.D.A. regulator, said that in retrospect, scientists had been too slow to adapt to those recommendations. They had known from previous disease outbreaks that plasma treatment is likely to work best when given early, and when it contained high levels of antibodies, he said. “Somehow we didn’t really take that as seriously as perhaps we should have,” he said. “If there was a lesson in this, it’s that history actually can teach you something.” Today, several medical centers have largely stopped giving plasma to patients. At Rush University Medical Center in Chicago, researchers found that many hospitalized patients were already producing their own antibodies, so plasma treatments would be superfluous. The Cleveland Clinic no longer routinely administers plasma because of a “lack of convincing evidence of efficacy,” according to Dr. Simon Mucha, a critical care physician. And earlier this year, Mount Sinai stopped giving plasma to patients outside of a clinical trial. Dr. Bouvier said that she had tracked the scientific literature and that there had been a “sort of piling on” of studies that showed no benefit. “That’s what science is — it’s a process of abandoning your old hypotheses in favor of a better hypothesis,” she said. Many initially promising drugs fail in clinical trials. “That’s just the way the cookie crumbles.” Plasma’s future Some scientists are calling on the F.D.A. to rescind plasma’s emergency authorization. Dr. Luciana Borio, the acting chief scientist at the agency under President Barack Obama, said that disregarding the usual scientific standards in an emergency — what she called “pandemic exceptionalism” — had drained valuable time and attention from discovering other treatments. “Pandemic exceptionalism is something we learned from prior emergencies that leads to serious unintended consequences,” she said, referring to the ways countries leaned on inadequate studies during the Ebola outbreak. With plasma, she said, “the agency forgot lessons from past emergencies.” While scant evidence shows that plasma will help curb the pandemic, a dedicated clutch of researchers at prominent medical institutions continue to focus on the narrow circumstances in which it might work. Dr. Arturo Casadevall, an immunologist at Johns Hopkins University, said many of the trials had not succeeded because they tested plasma on very sick patients. “If they’re treated early, the results of the trials are all consistent,” he said. A clinical trial in Argentina found that giving plasma early to older people reduced the progression of Covid-19. And an analysis of the Mayo Clinic program found that patients who were given plasma with a high concentration of antibodies fared better than those who did not receive the treatment. Still, in March, the N.I.H. halted a trial of plasma in people who were not yet severely ill with Covid-19 because the agency said it was unlikely to help. With most of the medical community acknowledging plasma’s limited benefit, even the Fight Is In Us has begun to shift its focus. For months, a “clinical research” page about convalescent plasma was dominated by favorable studies and news releases, omitting major articles concluding that plasma showed little benefit. Now, the website has been redesigned to more broadly promote not only plasma, but also testing, vaccines and other treatments like monoclonal antibodies, which are synthesized in a lab and thought to be a more potent version of plasma. Its clinical research page also includes more negative studies about plasma. Nevertheless, the Fight Is In Us is still running Facebook ads, paid for by the federal government, telling Covid-19 survivors that “There’s a hero inside you” and “Keep up the fight.” The ads urge them to donate their plasma, even though most blood banks have stopped collecting it. Two of plasma’s early boosters, Mr. Lebovits and Ms. Berrent, have also turned their attention to monoclonal antibodies. As he had done with plasma last spring, Mr. Lebovits helped increase acceptance of monoclonals in the Orthodox Jewish community, setting up an informational hotline, running ads in Orthodox newspapers, and creating rapid testing sites that doubled as infusion centers. Coordinating with federal officials, Mr. Lebovits has since shared his strategies with leaders in the Hispanic community in El Paso and San Diego. And Ms. Berrent has been working with a division of the insurer UnitedHealth to match the right patients — people with underlying health conditions or who are over 65 — to that treatment. “I’m a believer in plasma for a lot of substantive reasons, but if word came back tomorrow that jelly beans worked better, we’d be promoting jelly beans,” she said. “We are here to save lives.”’ Source link Orbem News #boom #Covid19 #learn #plasma

0 notes

babyatm1 · 4 years ago

Text

Sorts Of Wills

Will Writing For The Smart Individual - How To Compose Your Own Last Will And Testament

Content

If You Don'T Want To Use A Solicitor

Indication Your Will In Front Of Witnesses.

To Establish That Will Care For Your Minor Children

Secret Records To Have Alongside Your Last Will And Also Testament.

When Should You Get Legal Recommendations To Compose Your Will?

Making Older People'S Voices Heard.

Full An Estate Tax Form.

Making Use Of A Lawyer To Compose Your Will

What Is Probate?

If You Don'T Wish To Use A Lawyer

Information about wills, including exactly how to make one and what occurs if you pass away without a will. It's possible that your will may never ever require to be updated-- or you may choose to upgrade it regularly. Remember, the only version of your will that matters is the most current valid one in existence at the time of your death. We acquired some kinds online, as well as they are so overwhelming that we have not touched them in both months given that we acquired them and most likely never ever will.

Your Will is your last chance to express your desires when it concerns your building, your money, as well as your kids if they are minors. There are lots of various other reasons you require a will which I will enter below. Among one of the most important records you will ever before complete in your life is your Last Will as well as Testament. Note that I'm not an attorney and nothing here need to be considered real, legal guidance.

Indication Your Will In Front Of Witnesses.

youtube

To Determine That Will Care For Your Minor Children

A person (called a 'personal representative') appointed by a testator to execute the directions laid out in their will. An individual whose descent can be traced to a specific individual. A lineal offspring means a person who remains in direct line to an ancestor for all generations (such as a kid, grandchild, great-grandchild, etc.).

PT is likewise the owner and also CEO of the individual money sector meeting and exhibition, FinCon. Based on our level of involvement, the personal service we got, and also the truth that we're supporting a good friend, I'm comfortable with the added $200 spent. Or if you're still unsure which path to take, why not look into Simply Answer?

Trick Files To Have Along With Your Last Will And Testimony.

Or, you can define in a living will specifically how much time you are kept to life on life support. A living will is your written guidelines on the type of vital clinical therapy you prefer and the size of time you desire it. It instructs your liked ones and your medical professionals with your dreams even if you are unable to communicate or unconscious. A living will help take the guesswork and also the sense of guilt out of your loved one's hands. It spells out precisely what life-sustaining medical treatment you intend to take place should you become incapacitated.

youtube

When Should You Obtain Lawful Guidance To Draft Your Will?

There's no complicated legal lingo that gets in the way of the experience. They've taken a notoriously daunting process and also made it a positive experience. Despite being a totally free tool, it's extremely contemporary and also well designed.

youtube

Each area is split simply, making it simple to monitor your progress. It makes the procedure of finishing a will on your own very pain-free, even if you've never completed a will before.

The modifications mirrored a Law Reform Commission study which discovered that 75 per cent of individuals who have a will leave whatever to their spouse, the attorney-general claimed.

The privileges of first relatives would certainly come, in order of value, after partners and children; parents; siblings; grandparents; aunties as well as uncles.

If an individual passes away and also has left a valid will, that person is stated to have died testate.

We intend to reveal why making a will is the most effective method to make sure your properties-- including your home, any kind of money in the bank as well as personal belongings-- wind up with who you want and in the most ideal way.

A 2008 study by the Public Trustee found 45 per cent of people in NSW did not have a will.

" The new legislation will expand the pool of individuals that can acquire in NSW and recognises that a number other territories in Australia include very first relatives under intestacy regulations," claimed Mr Hatzistergos.

" To soothe these emotional-charged circumstances and simplify the procedure of dividing an estate, it is important that intestacy legislations precisely mirror area perspectives with regard to who need to benefit."

The distinction between the two can have considerable repercussions for a beneficiary or descendant.

While you can usually dictate nearly any kind of terms of an estate distribution by will, each state has regulations that govern distribution of estates for those that die without a will, or intestate.

When an individual dies without a will, he is stated to have passed away intestate.

Some Territories call for just 1 witness, ... some don't allow you utilize interested witnesses (i.e. a beneficiary contingent or straight) ... and so on . Philip Taylor, aka "PT", is a Certified Public Accountant, blog owner, podcaster, partner, as well as papa of 3.

That claimed, developing a will is one of the most crucial obligations that you can do for your household. While writing a will sounds like a complicated task, it does not have to be. There are online tools that you can utilize to create a standard will.

While some types assert to be free, they call for credit card information to turn on a. "trial," or they're extremely limited without paid upgrades. FreeWill breaks this mold by supplying an online tool that's properly cost-free, no strings connected. choices for the very best online will platforms for the full outcomes.

Today, not only exist extra devices than ever that generate a precise, extensive will in simply a couple of mins, however a few of these tools are cost-free. As the name suggests, this online platform is a free area to construct your very own will. Does Not avoid conservatorship, which is when a court assigns a representative to handle your funds.

It has the ability to offer its device at no charge because FreeWill partners with nonprofit companies. FreeWill's questionnaire asks individuals if they desire to leave a portion of their estate to a philanthropic group when they die. By partnering with details organizations, FreeWill guarantees its item is cost-free for all-- and also it does good at the same time. After looking into numerous online will tools, you'll swiftly understand "totally free" is tough to come by.

What does a simple will cost?

The average cost of a simple will is about $300 to $1,000 in the US for 2020 according to multiple trusted sources. According to Nolo, “It's very common for a lawyer to charge a flat fee to write a will and other basic estate planning documents. Wills4Less: for a simple lawyer-drafted will is around $300.

Nevertheless, a conservatorship can be stayed clear of with aDurable Power of Attorney, which will allow you to appoint a person of choice to handle your funds in the event you end up being incapacitated. An estate, or any type of component of an estate, that is not distributed by a will.

You ought to review your will every 5 years and also after any type of significant modification in your life such as a new grandchild or moving residence. If you can not authorize the will, it can also be joined your part, as long as you remain in the area and also it is authorized at your direction. Nevertheless, https://northamptonshire.wills4less.co.uk/funeral-plans/ need to have the mental capacity to make the will, or else the will is invalid. Any kind of will joined your part has to contain a condition saying you comprehended the materials of the will before it was signed.

What should be included in a last will and testament?

When writing a will, you might note who should take care of your animals after you die, and what money they'll use to do so. Your last will and testament form can also include your wishes regarding funeral arrangements, too. Do you have a preference on where your funeral should be held?

This paper offers an agent the authority to make financial go on our part if we are ever before disabled. Along with the POA, we had to finish a Notification to Individual Doing Power of Lawyer (I presume this is Texas' means of seeing to it you know what powers you're quiting). Selecting the representative to give clinical power of attorney isn't a choice that need to be ignored. As an example, you can request in your living will that a feeding tube be withheld if you are terminally ill.

Making Older People'S Voices Heard.

Where is the best place to keep a will?

If you don't want your executor to know what your will says, you can place it in a sealed envelope, and ask that it only be opened upon your death. Your executor should store it in a safe place, such as his or her safe deposit box or personal safe at home.

As long as you have a couple of minutes, you can download your finished will online without the problem. FreeWill not only has a modern-day, smooth layout, yet it's extremely very easy to utilize. Inevitably, we found that as long as you can address a few standard questions about your household scenario and end-of-life wishes, you can make a will online with FreeWill. But, just how does this device compare to other totally free and paid resources? In this overview, we'll evaluate FreeWill to determine its pros, disadvantages, and also whether it's worth it.

Is FreeWill com really free?

Why is FreeWill free? FreeWill's no-charge product is made possible with the support of nonprofit organizations. Many of our will-makers choose to leave a portion of their estate to charity, and we hope you'll consider doing the same.

Making certain your youngsters will be looked after regardless of what takes place to you is an exceptional factor to compose a will. Updating your will with each new birth-- even though many boilerplate Wills cover the possibility that you might have a lot more youngsters-- is likewise a good suggestion.

How much should a Will Cost UK?

The costs of drawing up a will by a solicitor for: a simple will - can cost between £144 and £240. So, shopping around and finding someone good for the lower price could save you almost £100. a complex will – can cost between £150 and £300.

But if you desire legal recommendations today, checkout Just Solution. The data reveal that lots of people do not have a proper Last Will and also Testimony.

I did not create our initial will till after our earliest kid was born. We live numerous hrs away from our closest relative, as well as if something were to occur to both of us, the state of Texas would certainly decide who would care for our child. If you are wed, find the kind that suits both of your wishes and also has actually paragraphs committed to the treatment of small kids, if you have them. While using a free Will form isn't needed, it does make writing your will significantly less complicated than attempting to draw one up from scratch.

It is very important to name a guardian to take care of your minor or dependent youngsters in case you are the last surviving parent or the enduring moms and dad is unsuited to take care of them. You intend to pick a person that is not only ready to take on the responsibilities of increasing your kids till they turn 18 however that is additionally near you and your kids. Make certain to discuss this decision with both your kids as well as the possible guardian, as well as take into consideration calling an alternating guardian needs to something take place to your front runner. The testator, the individual making the will, must be at the very least 18 years old and of sound mind. Writing your own will is most likely not a critical product on your order of business.

What To Expect From Your Lawyer

If you're providing the authority to another person to choose for you, you're called the maker. Along with a will, it is very important to consider what you would want to occur if you were no longer able to make personal or economic choices prior to you die. A Personal Regulation as well as Enduring Power of Lawyer allow you choose somebody to manage your individual as well as monetary events if you are still active but unable to make decisions. There are various types of wills, each with certain formalities and also needs to make them valid.

Occasionally you may locate on your own requiring to update your will once you've completed your file. This is regular since life features normal modifications and difficulties. Whether you have actually had children, gotten wed, or altered your final dreams, upgrading your will is easy with FreeWill. distinctions between a trust and also a will, and you'll need to pick which is ideal for you.

How do you prepare a simple will?

How to write a will yourself 1. Look at some examples. There are plenty of example wills online. 2. List configuring Wills4Less... . 3. Think of everyone you may want to include. 4. Decide who gets what. 5. List those you are excluding. 6. Add any other instructions. 7. File it away. 8. Update as necessary.

Without a will, it is up to the state to determine what takes place to your building, which normally indicates your next of kin will obtain whatever. In general, a surviving spouse will be the front runner, followed by grown-up kids or other family members. Taking into consideration the amount of work as well as organization needed to fulfill these duties, it is essential to pick a person trustworthy and capable. While it's not likely that two parents would pass away at the exact same time, I sleep better in the evening recognizing that my other half as well as I have chosen ahead of time who will care for our kids in that unlikely event.

#Making a will #Will writing services #How to make a will #Fixed Fee Will Writing #Online Will Writing #Will Aid #Will Writing Specialist #will template #how to write a simple will #will writing services near me #legal will #online will #family will #simple will #how to end a will

0 notes